Professional Documents
Culture Documents
Volume Decline Associated With Aging, Alzheimer's Disease, and Socioeconomic Status: Structural Neuroimaging Across The Adult Life-Span
Volume Decline Associated With Aging, Alzheimer's Disease, and Socioeconomic Status: Structural Neuroimaging Across The Adult Life-Span
Program in Neurosciences
by
May 2008
such people, both at the University and at home, and many have contributed to this thesis.
Starting with the older adult volunteers in our neuroimaging experiments, their wisdom
and service have led me to wonder about all the positive aspects of lifelong development
and not just to fear growing old. From the staff of the Alzheimer Disease Research Center
(ADRC) responsible for pooling so many of these generous participants, I want to thank
Amy Buckley, Virginia Buckles, and Mary Coats for clinical assistance and participant
recruitment; Elizabeth Grant for database assistance; and Chengjie Xiong, David
Johnson, and Cathy Roe for discussion of statistical procedures. I am grateful to Bruce
Fischl, Anders Dale, Xiao Han, Rudolph Pienaar, Brian Quinn, and Andre van der
Kouwe from the Martinos Center for Biomedical Imaging in Boston for collaborating on
the application of their innovative magnetic resonance sequence. Within the Cognitive
Neuroscience and Neuroimaging Labs, I thank Daniel Marcus, Mohana Ramaratnam, and
Tim Olsen for database development and support; Dana Sacco, Erin Laciny, Jamie
Parker, Susan Larson, Kate O'Brien, Laura Williams, Amy Sanders, and Glenn Foster for
assistance with MRI and PET data collection; and my labmates, Luigi Maccotta, Ted
Satterthwaite, and Ben Shannon, for serving as friendly and stimulating neighbors. Based
programs, I appreciate how Brian Sullivan, Andrew Richards, Christy Durbin, Sally
ii
Vogt, and Anna Cook-Linsenman (formerly of the Buckner lab) keep everyone
humming.
whom I have learned from, emulate, and can look up towards with admiration and
gratitude. Denise Head, Daniel Goldberg, Martha Storandt, Mark Mintun, John Morris,
Joel Price, Brad Schlaggar, Martha Storandt, Avi Snyder, and David Van Essen are all
exemplary scientists, who have shared their expertise generously with me as mentors. No
one sets a higher standard than my advisor, Randy Buckner, who has given selflessly of
his resources and shown by example how to think and work productively to advance our
understanding of the brain. “What would Randy do?” has already become and I am sure
parents, Jim and Carol; my beloved wife, Saori; and my children, Naomi and Noah. The
iii
TABLE OF CONTENTS
Acknowledgements………………………………………………………………….. ii
Table of Contents……………………………………………………………………. iv
List of Figures……………………………………………………………………….. v
List of Tables………………………………………………………………………… vi
Abstract…………………………………………………………………………........ vii
iv
LIST OF FIGURES
Figure 2.2 Cross-sectional plots of gray and white matter, normalized for head
size …………………………………………………………………… 27
Figure 3.1 Multi-echo FLASH (MEF) imaging from one older adult participant.. 44
Figure 3.2 Post-processing and null results for three-month discrimination with
Figure 4.1 Cross-sectional plot of brain volume in nondemented adults over the
adult life-span………………………………………………………… 69
of socioeconomic status………………………………………………. 71
Figure 4.4 The relationship between adjusted whole brain volume and SES is
dementia……………………………………………………………… 76
Figure 5.1 Thesis results within a multiple factor framework of brain aging…… 83
v
LIST OF TABLES
Table 2.2 Estimated gray, white, and whole-brain volume (WBV) by age
Table 3.1 Longitudinal sample with complete baseline and follow-up MEF
images………………………………………………………………… 43
vi
ABSTRACT OF THE DISSERTATION
by
neurodegeneration in AD relates to aging (a risk factor for AD) and socioeconomic status
(SES, a protective factor for AD). Three quantitative structural magnetic resonance
imaging (MRI) studies toward this goal are described. The first study characterized cross-
sectional and longitudinal rates of whole brain volume decline in nondemented adults and
compared these normal rates to atrophy measured early in symptomatic AD. The results
Standard imaging methods used in this initial study required almost two years of
samples. The second study aimed to reduce this follow-up interval to a more clinically
vii
practical three months, principally through the implementation of recently developed
multi-echo fast low-angle shot (MEF) MR sequences. Null results for this three-month
The third study derived from the initial finding of brain aging in the absence of
dementia. SES is one factor known to protect against dementia incidence. We found that
older adults with high SES have reduced brain volume (cross-sectional result) and more
rapid volume loss (longitudinal result) than less privileged peers. Additional findings
based on amyloid imaging with positron emission tomography (PET) and clinical follow-
up suggest that the capacity of individuals with high SES to cope longer with preclinical
AD pathology, consistent with the reserve hypothesis, may help to explain these
counterintuitive main results. Implications of this thesis research and possible future
directions are discussed within the context of a multiple factor framework of brain aging.
viii
CHAPTER 1
Life-span brain morphometry. In 1907, Alois Alzheimer linked brain atrophy with a new
disease that would come to bear his name (AD). He wrote in his case report on Auguste
D., “The post-mortem showed an evenly atrophic brain without macroscopic focal
degeneration…Only a tangle of fibrils indicates the place where a neuron was previously
located…Many neurons, especially the ones in the upper layer, have completely
disappeared” (Alzheimer et al., 1995). In the same report, Alzheimer also identified
widespread “miliary foci,” since recognized as β-amyloid (Aβ) plaques (Glenner and
neuronal degeneration, atrophy, and dementia (Hardy and Selkoe 2002, Walsh and
Selkoe 2004). Other models start differently (for example, Lee et al., 2004, de la Torre
2004), but they end the same, with at least three related implications for structural
neuroimaging, the method on which this thesis is based. First, given the link between AD
damage at the macroscopic structural level (Jack et al., 2002, Silbert et al., 2003,
neuroimaging is thus increasingly oriented toward early disease detection (DeKosky and
1
structural change requires careful comparison to normal brain morphometry (Giedd 2004,
Raz 2004). I will accordingly begin with an overview of normal brain aging, and then
This thesis samples over an extended period of human adulthood from 18 to 97.
Within this age range, older adults (≥ 65) account for a growing proportion of the
developed world’s population and carry the heaviest burden of chronic disease (Goulding
et al., 2003). Aging research thus tends to focus on older adults. Does the structure of
their brains normally differ from that of younger adults (~18-44)? Starting at the cellular
level, in terms of neuron number, the emerging consensus favors overall stability (<10%
decline between age 20 and 90; Haug et al., 1984, Pakkenberg et al., 2003), with limited
areas of age-related loss (for example, in the substantia nigra; reviewed in Morrison and
Hof 1997, Turlejski and Djavadian 2002). Preliminary data also suggest minimal loss
with age in the number of glia (Pakkenberg et al., 2003). In contrast to the numerical size
stability of neurons, dendritic spine counts and spine density estimates are markedly
reduced in the old (for example, over 40% less in apical dendrites of layer III pyramidal
neurons around the superior temporal sulcus; Duan et al., 2003; reviewed in Uylings and
de Brabander 2002). Consistent with cortical spine loss, synapse (specifically, input)
elimination has been demonstrated in the parasympathetic ganglion of the aged mouse
(Coggan et al., 2004). Subcortically, in white matter, autopsy studies have increasingly
estimates of adult-span white volume decline run as high as 25% (Pakkenberg et al.,
2
2003, Svennerholm et al., 1997), and these may underestimate fiber loss, which appears
to decline exponentially with age (Marner et al., 2003). This pattern of late acceleration,
oligodendrocytes all point to the possibility that microscopic white matter lesions
represent a distinct senescent process common after middle age (Peters and Rosene 2003,
Bartzokis 2004a).
human samples and the time demands of characterizing neurons and glia (for discussion
studies employ the efficient extreme group design, comparing oldest to youngest adults
this sampling limitation comes from the following plots of synapse density in 21 brains, 8
from adults over age 60 and 7 from infants under one (Huttenlocher 1979).
3
FIGURE 1.1
Synapses/mm3 x 108
Synapses/Neuron x 104
Figure 1.1. Age extrapolation issues and synapse estimates from layer III of human
middle frontal gyrus from Huttenlocher (1979). (A) Raw synapse numbers from
electron photomicrographs. Note non-uniform x-axis and skewed age distribution. (B)
Synapse numbers accounting for changes in neuron number; note changed x-axis
scaling.
The often cited plot is on the left (Figure 1.1A); it shows that electron
year of life and are generally higher in early childhood than in old age. The plot on the
right (Figure 1.1B) provides a moderated view by accounting for differences in neuron
number with age. Subsequent investigations of pediatric samples have replicated the
essential finding that synaptic density peaks within the first few years of life; they also
Feinberg et al., 1990, Huttenlocher 2002). However critical evaluation of the age
distribution in Figure 1.1, particularly accounting for the non-uniform age-axis (often a
4
sign of biased sampling), shows the 21-brain sample “ranging from newborn to 90 years”
has a gaping hole through 80% of that range. The same can thus be said about the fit line
through so little data. This example prompts two related observations. First,
understanding of human aging tends to be weakest in the working adult range (~25-60),
perhaps because this group works to survive into old age prior to autopsy. Second, it may
be helpful to distinguish between aging in the familiar sense of growing old and less fit
(senescent aging) versus aging in the constitutive sense of courses of change that extend
over the lifetime (physiological aging, a gap in the understanding of which Figure 1.1
highlights).
generally favoring macroscopic measures, such as brain weight and volume. How does
normal aging appear with more data at the macroscopic level? Early autopsy reports did
not account for the weight (Dekaban 1978) or volume (Davis and Wright 1977) of
ventricular CSF; they modeled changes with age as flat prior to around age 50, and
declining thereafter (~10% total; though see Pakkenberg and Voigt 1964, Miller et al.,
1980). However, more recent autopsy (Svennerholm et al., 1997) and cross-sectional
young adulthood, with the largest samples showing mild acceleration after middle age
(Good et al., 2001, DeCarli et al., 2004). In contrast to the whole brain pattern of early
decline, white volume estimates remain stable (Pfefferbaum et al., 1994, Blatter et al.,
1995, Guttmann et al., 1998) or increase slightly (Courchesne et al., 2000, Ge et al., 2002,
Sowell et al., 2003, Jernigan and Fennema-Notestine 2004, Walhovd et al., 2005,
5
Kruggel 2006) until middle-age (age 40 to 60). White volume decline follows and
accelerates in old age, in agreement with the recent autopsy findings on fiber loss
discussed above. MRI studies that report minimal white volume decline (Van Laere and
Dierckx 2001) tend to have fewer or healthier older participants, reinforcing the
must assume that older and younger individuals differ only with respect to their ages and
not their birth cohorts or other variables. Longitudinal studies are now possible to test
cross-sectional estimates from the larger sample. At least seven prior studies have
quantified longitudinal, whole brain decline in nondemented adults over 60. Six (Chan et
al., 2001, Wang and Doddrell 2002, Liu et al., 2003, Resnick et al., 2003, Thompson et
al., 2003, Jack et al., 2004) documented annualized loss of about 0.5% (0.37 to 0.88),
whereas one (Tang et al., 2001) reported a rate of 2.1%. Longitudinal studies sampling
from younger adults have found slower, not non-zero, rates of decline (0.2-0.3%/yr;
Giedd et al., 1999, Liu et al., 2003), again consistent with an acceleration of white
Figure 1.2 shows data from two independent longitudinal studies designed to
provide insight on physiological aging (Liu et al., 2003, Raz et al., 2005). The left graph
(Figure 1.2A) plots whole brain volume adjusted for intracranial volume, derived using
automated segmentation (see legend). The right graph (Figure 1.2B) plots the volume of
6
the lateral prefrontal cortex, also adjusted for intracranial volume, but derived from
manual measurements. Each line represents an individual study participant. Brain volume
FIGURE 1.2
Adjusted Volume (cm3)
A B
Figure 1.2. Longitudinal time-courses of normal brain volume decline. (A) Whole brain
volume covariance adjusted (statistically matched) for intracranial volume from 90
healthy volunteers, concentrated at baseline in the 14 to 55 age range (mean 37), with
repeat imaging after 3.5 years. Volume was measured via automated gray/white/csf
segmentation of longitudinally registered scan pairs from each study participant (from
Figure 2 in Liu et al., 2003). (B) Manually segmented lateral prefrontal cortical volume
from 72 healthy volunteers, 20 to 77 at baseline (mean 52), with repeat imaging after 5
years (from Figure 6 in Raz et al., 2005).
confirmation (Ball et al., 1997, McKeel et al., 2004); it is uncertain when the disease
process starts in any given individual (Borenstein et al., 2006). Cross-sectional study of
AD progression would call for individuals to be matched on all variables other than time
since disease onset. Given the uncertainty surrounding onset, longitudinal neuroimaging
has a key role to play in characterizing the progression of AD, since age of onset is
naturally matched within subject (Kantarci and Jack 2003, Glodzik-Sobanska et al.,
7
2005). A handful of reports on serial MRI have found whole brain atrophy accelerates in
AD, but differ as to the magnitude. The difference in annualized atrophy rates between
during follow-up (0.8%) and those with slow-progressing (0.6%) and fast-progressing
(1.4%) DAT at baseline suggests that dementia severity and atrophy rate are associated
(Jack et al., 2004). Accordingly, most reports on more severely demented samples
estimate whole brain atrophy rates more rapid than 2% per year (Chan et al., 2001, Wang
et al., 2002, Thompson et al., 2003, Schott et al., 2005), consistent with a nonlinear
(accelerating) atrophy model of DAT (Chan et al., 2003, Rusinek et al., 2004).
Regarding the anatomy of atrophy in AD, a recent report from our laboratory
(Buckner et al., 2005) compared the spatial distribution of maps from five different
hypothesis regarding the natural history of AD. Nonlinear registration (see below) was
used to estimate atrophy at the voxel level in participants with DAT. Compared to
prefrontal, orbitofrontal, and inferior parietal regions (Jernigan et al., 2001, Ohnishi et al.,
2001, Sowell et al., 2003, Salat et al., 2004, Raz et al., 2005), atrophy in DAT was most
cortex, including the precuneus, posterior cingulate, retrosplenium, and lateral posterior
parietal regions, consistent with prior studies (Brun and Gustafson 1976, Callen et al.,
2001, Ohnishi et al., 2001, Scahill et al., 2002, Yoshiura et al., 2002, Boxer et al., 2003,
Miller et al., 2003, Thompson et al., 2003, Karas et al., 2004, Chetelat et al., 2005,
8
Pennanen et al., 2005). Positron emission tomography (PET) maps of default activity
(areas receiving more blood flow when young healthy participants were not engaging in
2001) and MRI maps of memory retrieval (areas with increased signal when young,
healthy participants correctly recognize old versus new items; reviewed in Wagner et al.,
convergence between maps of functional and metabolic activity in young adults and
pathology in late-onset DAT suggests functional or metabolic activity early in life may
Morphometric methods. How is brain structure measured to generate the findings and
hypotheses surveyed above? My interest is with individual brain change over time, but a
differences serves as a reminder that Morton (1849), Broca (1861), and Galton (1888),
among other nineteenth-century scientists, pioneered the field of head and brain
include the invention of a pneumatic device for assessing intracranial volume (Davis and
Wright 1977) and the random sampling, 3-D dissector method of counting neurons
In the 1970s, the developers of modern MRI variously solved the problem of 3-D
NMR (Damadian 1971, Lauterbur 1973, Mansfield and Maudsley 1977). The conceptual
basis for all spatial encoding schemes is the linear equation relating magnetic field
9
strength to the resonance (Larmor) frequency of the hydrogen proton. Magnetic field
strength can be regularly varied using gradient coils, such that for a given gradient and
radio frequency (RF) bandwidth, protons at a known fixed interval (spatial frequency)
along a known slice thickness can all be made to precess at multiples of the same known
Larmor frequency. Intrinsic tissue properties (T1, T2, and proton density, PD) and
received from these spatially selected protons during the readout interval. Spin-lattice
relaxation time (T1) or spin-spin relaxation time (T2) can be emphasized, depending on
the time between excitations (repetition time, TR) and the time between gradient switches
using a new multi-echo fast low-angle shot (MEF) sequence, from which intrinsic tissue
property estimates (T1, T2*, and PD) can be derived (Fischl et al., 2004).
Several strategies exist for next transforming a high resolution (~cubic mm) brain
image into morphometric data. Manual methods based on tracing the outline of known
anatomical boundaries are considered the gold standard (for example, Jernigan et al.,
2001, Raz et al., 2004, Head et al., 2005). However, automated methods offer the
potential for greater throughput and extensibility. Within the category of automated
volumetric methods, linear (Woods et al., 1992, Snyder 1996, Smith et al., 2002, Buckner
et al., 2004) and nonlinear (Christensen et al., 1996, Miller 2004) registration is used in
this research. In general, the goal of registration is to match for and thereby eliminate
uninteresting sources of structural variance such as scanner drift, head positioning, and
head size. Registration to stereotaxic atlases also enables discussion of space to occur in
10
the same language. The highest parameter linear registration is a 12-parameter affine; it
represents a procedure for minimizing the difference (registration error) between a source
and target image by translating, rotating, stretching, and skewing the source image. An
study from our lab (Buckner et al., 2004), is whether head size accounts for the scaling
manual (total intracranial volume, TIV) and registration-based (estimated TIV, eTIV)
head size estimates, and both were independent of brain atrophy in demented samples.
These findings indicate that differences in head size drive image scaling when the
difference between a source MRI and sample-representative target atlas are minimized by
linear registration. Head-size corrected estimates are reported either as ratios or residuals
of eTIV (Mathalon et al., 1993, Sanfilipo et al., 2004, Van Petten 2004). Residual
correction is more robust against group differences in head size; however, for
comparisons in which these have been explicitly studied and ruled out (Buckner et al.,
2004), we have used ratio correction as the more conventional (for example, (Pantel et
al., 2004, DeCarli et al., 2004, Kruggel 2006) and transparent alternative (see Chapters 2
and 3).
error to zero, under assumptions that brain images behave according to known material
properties (for example, like a viscoelastic fluid; for a review of how fluid warping is
being applied, see May et al., 2006). The extent of voxel-wise contraction or expansion
11
embedded within the nonlinear transformation provides an estimate of regional volume
change, though the precise relationship between the magnitude and spatial distribution of
normal old aging and DAT (Buckner et al., 2005, discussed above).
registration that ranges from linear to “global nonlinear,” the latter involving some
nonlinear warping but with final registration error greater than zero (Ashburner and
estimates and viewed in the context of metric whole brain gray and white differences that
drive them (Bookstein 2001, Tisserand et al., 2002, Mehta et al., 2003, Davatzikos 2004).
Unfortunately, these metric estimates often go unreported in VBM papers and negative
rely exclusively on this method (for example, Maguire et al., 2000, Colcombe et al.,
Chapter 4), there are few studies that demonstrate modification of the downward slopes
illustrated in Figure 1.2. Sluming and colleagues (2002) reported that whole brain volume
was less correlated with age in a group of professional musicians than matched
12
nonmusicians controls. VBM analysis with a lower statistical threshold in an a priori
region of left frontal cortex confirmed that gray volume was significantly increased there
in musicians. A more recent VBM study of older adults found a significant interaction
between age and estimates of maximal oxygen uptake, such that higher fitness was
associated with greater than age-predicted gray volume throughout association cortex and
greater than age-predicted white volume, particularly in the frontal lobes (Colcombe et
al., 2003). Both these studies suggest long-term motor-related activity moderates age-
Five other reports on normal structural modifiers fail to find such moderation for
role. Coffey and colleagues (1999) report a very weak but significant correlation between
education and cerebral spinal fluid (CSF) volume in 320 normal older adults (such that
the most educated had more sulcal CSF). A meta-analysis of 33 published papers on
volume decline in the hippocampus also failed to find moderation by fitness of memory,
as assessed by cognitive testing (Van Petten 2004). Again, the trend pointed in the
amplifying direction, especially with younger samples (such that those remembering
most had the smallest hippocampi). More recently in children, vocabulary gains (Sowell
et al., 2004) and superior IQ (Shaw et al., 2006) have been linked to distributed regions of
factors moderate the risk of dementia. In particular, education, occupation, literacy, IQ,
13
and active lifestyle all have experimental support as protective factors against DAT
(Gurland 1981, Zhang et al., 1990, Whalley et al., 2000, Fratiglioni et al., 2004, Manly et
al., 2005, Valenzuela and Sachdev 2006). The evidence for modification generally falls
into two categories: a negative correlation with indices of disease expression and a
positive correlation with indices of pathological severity. For example, more educated
individuals have been linked to a lower incidence (reduced risk) of dementia diagnosis
(Launer et al., 1999, Valenzuela and Sachdev 2006). In contrast, at the cusp of dementia
or in patients otherwise matched for clinical severity, cognitive performance and glucose
metabolism have been found to decline more rapidly in the more educated (Stern et al.,
1992, Amieva et al., 2005, Scarmeas et al., 2006). A combination of direct relationships
between education and pathology and between education and physiological brain aging
might conceivably contribute to these findings (Snowdon 2003, Shaw et al., 2006).
However, the reserve hypothesis offers the most parsimonious explanation. The
hypothesis is that education and related variables moderate the relationship between
pathology and disease expression (Katzman 1993, Satz 1993, Stern 2002, Bennett et al.,
2005, Scarmeas and Stern 2004, Bennett et al., 2005, Stern 2006, Roe et al., 2006). We
will return to the reserve hypothesis as a potential explanation for our finding that brain
14
CHAPTER 2
ABSTRACT
Objective: To test the hypotheses 1) that whole-brain volume decline begins in early
magnetic resonance images (MRIs) were obtained from 370 adults (age 18 to 95).
Participants over 65 (n = 192) were characterized using the Clinical Dementia Rating
(CDR) as either nondemented (CDR 0, n = 94) or with very mild to mild dementia of the
Alzheimer type (DAT, CDR 0.5 and 1, n = 98). Of these older participants, 79 belonged
to a longitudinal cohort and were imaged again a mean 1.8 years after baseline. Estimates
of gray matter (nGM), white matter (nWM), and whole-brain volume (nWBV)
normalized for head sizes were generated based on atlas registration and image
individuals across the adult life-span revealed a strong linear, moderate quadratic pattern
of decline beginning in early adulthood, with later onset of nWM than nGM loss. Whole-
brain volume differences were detected by age 30. The cross-sectional atrophy model
15
(mean decline of -0.45% per year). In those individuals with very mild DAT, atrophy rate
more than doubled (-0.98% per year). Conclusions: Nondemented individuals exhibit a
slow rate of whole-brain atrophy from early in adulthood with white-matter loss
beginning in middle age; in older adults, the onset of DAT is associated with a markedly
INTRODUCTION
Pathological brain processes that lead to dementia coexist with normal aging
processes that also influence the brain but do not manifest as disease. To better
understand the nature of normal brain development in advanced aging and how the
earliest stages of dementia of the Alzheimer type (DAT) cause departure from that
trajectory, we report here a large-sample study of 370 adults age 18 to 95. The goals of
this study were to characterize the normal development of whole-brain volumes in the
longitudinal estimates, to what degree the presence of early-stage DAT causes departure
and longitudinal estimates of brain change. Cross-sectional estimates are efficient in that
a single measure can be used as the dependent measure. To the degree that different
normal individuals have predictable brain sizes and changes in brain size, a single point
estimate may be informative regarding their likely future course and risk of disease.
16
However, reviews of the structural aging literature highlight the need for longitudinal
data because of between-subject variance (Raz 2000, Uylings and de Brabander 2002,
Kantarci and Jack 2003). Longitudinal data reduce between-subject variance by using an
individual as his or her own baseline and also control for differences that potentially
when people were born (secular effects). MRI is readily able to obtain longitudinal data
through repeated imaging of the same person over time (reviewed in Raz 2004).
(Giedd et al., 1999), allows three basic questions to be addressed. First, to what extent
and at what age does nondemented aging associate with cross-sectional brain volume
nondemented adults under 50 (Davis and Wright 1977, Miller et al., 1980, Matsumae et
al., 1996, Guttmann et al., 1998, Ge et al., 2002), whereas others find volume loss in this
age range (Pfefferbaum et al., 1994, Giedd et al., 1999, Courchesne et al., 2000, Rovaris
et al., 2003, Sowell et al., 2003, Salat et al., 2004), a difference possibly related to
differential contributions of gray- and white-matter loss to brain aging (Raz 2004).
Second, does the cross-sectional rate of atrophy in nondemented older adults match the
that cohort and secular effects are minimal and volume loss progresses in a predictable
17
manner in the absence of dementia. Finally, to what extent does the rate of whole-brain
atrophy accelerate in early-stage DAT? The available reports addressing this question
have found significant acceleration, but differ as to its magnitude (Cardenas et al., 2003,
METHOD
occasions separated by an extended interval to allow for longitudinal data analysis (1.0 to
3.9 year interval; mean = 1.8 years). Twenty additional individuals were scanned twice at
reliability. Participants were paid for their participation and gave informed consent in
Data from subsets of the participants have been used in previous studies (Salat et al.,
Young and middle-aged adults were recruited from the Washington University
community. Nondemented and demented older adults were recruited exclusively from the
ongoing longitudinal sample of the ADRC. The ADRC volunteers are more likely than
the population of the St. Louis metropolitan area to have a high school education, and
volunteers with severe comorbidities such as major depression or disabling stroke are
excluded (Villareal et al., 2003). Approximately 40% of ADRC participants who met the
18
study’s clinical criteria (nondemented or dementia restricted to DAT) declined to
state exam (MMSE; Folstein et al., 1975) between ADRC participants who did and did
not undergo MRI. Dementia severity was quantified using the Clinical Dementia Rating
(CDR; Morris 1993) scale for all ADRC volunteers, and recruitment for MRI was
assessment and participation in the MRI session was 101 days (range = 3 to 332 days).
The 98 participants with DAT exhibited very-mild (CDR 0.5; n = 69) to mild (CDR = 1,
n = 29) dementia severity. Of the 205 older adults who underwent MRI, 13 (6%; 7 CDR
= 1, 3 CDR = 0.5, 3 CDR = 0) did not complete the imaging protocol; one dropped out on
repeat imaging. Although several DAT participants had cognitive test scores (e.g.,
MMSE) that might qualify for classification as mild cognitive impairment, a CDR score
clinical progression and neuropathological diagnosis at autopsy (Berg et al., 1998, Morris
et al., 2001, Galvin et al., 2005). Demographic and clinical data for participants are
19
TABLE 2.1. Sample Characteristics
N (cross-sectional) 127 51 94 69 29
20
Image acquisition. Multiple (three or four) high-resolution structural T1-weighted
empirically optimized for gray-white contrast (repetition time (TR) = 9.7 ms, echo time
(TE) = 4 ms, flip angle (FA) = 10, inversion time (TI) = 20 ms, delay time (TD) = 200
ms, 256 x 256 (1 mm x 1 mm) in-plane resolution, 128 sagittal 1.25 mm slices without
gaps, time per acquisition = 6.6 min). Participants were provided cushioning, head
phones, and a thermoplastic face mask for communication and to minimize head
movements. Positioning was low in the head coil (toward the feet) to center the field of
view on the cerebral hemispheres. The MP-RAGE images were acquired as the second
part of a 70-minute CAP protocol that also included fast low angle shot (FLASH)
gradient echo, turbo spin echo (TSE), and diffusion tensor imaging (DTI) acquisitions.
The DTI data have been reported elsewhere (Head et al., 2004).
Image analysis. Normalized gray-matter (nGM; gray parenchyma within the entire
(nWM), and whole-brain volume (nWBV; gray plus white parenchyma) were computed
for each image session. The procedure was based on a validated, open-source
segmentation tool (Zhang et al., 2001, Smith 2002). Prior to image segmentation, the
images were pre-processed to normalize for head-size and intensity variation that might
21
Pre-processing included multiple steps. Head-size normalization used a validated
minimally biased by atrophy. Images were corrected for inter-scan head movement and
spatially warped into the atlas space of Talairach and Tournoux (1988). The template
representative sample of the young (n = 12) and nondemented old (n = 12) adults. The
use of a combined template has been shown to minimize the potential bias of an atlas
between the first MP-RAGE image and the atlas target (Snyder 1996). The remaining
MP-RAGE images were registered to the first (in-plane stretch allowed) and resampled
via transform composition into a 1-mm isotropic image in atlas space. All images were
visually inspected to verify appropriate atlas transformation. The result was a single,
high-contrast, averaged MP-RAGE image in atlas space (see Figure 2.1). Subsequent pre-
processing steps included skull removal by application of a loose-fitting atlas mask and
inhomogeneity model.
average image as cerebral spinal fluid (CSF), gray, or white matter (Zhang et al., 2001,
Smith 2002). This segmentation starts with an initial estimation step to obtain and
22
classify tissue parameters. An expectation-maximization algorithm then updates class
labels and tissue parameters in order to iterate toward the maximum likelihood estimates
the probability with which voxels of a given intensity are estimated to belong to each
tissue class.
FIGURE 2.1
Normalized volumes were computed as the proportion of all voxels within the brain mask
occupied by gray (nGM), white (nWM), or gray plus white (nWBV, equivalent to 100 –
%CSF) voxels. The unit of normalized volume is percent, which represents the
23
Test-retest measurement reliability. In order to estimate measurement reliability,
normalized volumes for the same person were compared over two imaging sessions
change. Twenty individuals contributed to the test-retest group (young, n = 16; middle-
aged, n = 1; older, n = 3), with a mean delay of 21 days between test and retest (range 1
to 64 days). The mean absolute percentage difference (MAPD, the absolute difference
between test and retest volumes divided by the overall mean, expressed in percent) was
0.92% for nGM (CI 0.53-1.30), 0.80% for nWM (CI 0.5-1.1), and 0.49% for nWBV (CI
0.28-0.71). The coefficients of variation (CV, the standard deviation of the difference
between test and retest volumes divided by the overall mean, expressed in percent) were
1.24% (nGM), 1.04% (nWM), and 0.68% (nWBV). The interclass correlations between
values paired by participant, but randomly assigned to test or retest, were high (r[nGM] =
Cross-sectional analysis. Normalized volumes were plotted against age for the 370
unique participants. Statistical analysis was conducted with the JMP software package
(SAS Institute, Cary, North Carolina). Hierarchical polynomial regression was used to
test between linear and curvilinear models of cross-sectional volume as a function of age.
With the sample restricted to one volume measurement per nondemented individual,
higher order terms of the subject’s age-at-scan were tested until they no longer
contributed significantly to the model; the resulting models are referred to as cross-
sectional, nondemented aging curves. Normalized volumes in the older DAT and older
24
nondemented samples were then compared using analysis of covariance with nGM,
nWM, or nWBV as the dependent measure and age, gender, and dementia status as
cofactors.
Longitudinal analysis. The longitudinal analysis was restricted to the most reliable
whole-brain data and sought to quantify the whole-brain atrophy rate within older
nondemented and DAT individuals. Atrophy rate was computed as the slope of the line
expressed as percent change per year. For example, in a participant with two scans,
atrophy rate was computed as nWBV at scan 2 minus nWBV at scan 1, divided by the
covariance was again used to test for differences in atrophy rate based on age, gender,
longitudinal data, atrophy rate was estimated from the cross-sectional, nondemented
aging curve and compared with the longitudinal, nondemented atrophy rate. Atrophy rate
was estimated from the cross-sectional curve by expressing its slope as a percentage of
nWBV at the mean age of the older, nondemented sample (age = 78, nWBV = 74.8%).
For graphical comparison, trendlines were plotted for nondemented and demented aging.
The slope of the nondemented trendline, for example, was determined by the mean
atrophy rate of the nondemented, longitudinal sample; the y-intercept was determined by
25
interpolating nWBV from the nondemented, cross-sectional sample (mean age = 81,
nWBV = 74.1%; DAT trendline drawn equivalently, mean age 78, nWBV = 72.0%; see
Figure 2.3B).
RESULTS
Cross-sectional. The cross-sectional dataset is plotted in Figures 2.2 and 2.3A and
decline in normalized gray matter (nGM; r = -0.91, F[1,270] = 1311.00, p < 0.001), white
matter (nWM; r = -0.25, F[1,270] = 17.71, p < 0.001), and whole-brain volume (nWBV;
significant when considering the age range of 18 to 30 for nGM (r = -0.20, F[1,121] =
4.91, p < 0.05) and nWBV (r = -0.19, F[1,121] = 4.58, p < 0.05), but not for nWM (F <
1). Considering the full age range, adding a quadratic term significantly improved the
models of nGM (F[2,269] = 681.24, p < 0.001, R2 = 0.84), nWM (F[2,269] = 18.96, p <
0.001, = R2 = 0.12), and nWBV (F[2,269] = 533.32, p < 0.001, R2 = 0.80). The addition
of a cubic term failed to add a significant effect for any model (F < 1).
2.3A illustrate that individuals with DAT (CDR = 0.5 and 1) exhibited volume reduction
age, gender, and dementia status as covariates was significant for nGM (F[7, 184] =
26
20.79, p < 0.001), nWM (F[7.184] = 3.14, p < 0.01), and nWBV (F[7, 184] = 19.80, p <
0.001), with main effects for all three covariates. Post-hoc testing indicated women had
more nGM (43.0% vs. 42.2%, p = 0.051), nWM (30.9% vs. 30.1%, p < 0.05), and nWBV
(73.9% vs. 72.3%, p < 0.01) than men. The presence of DAT was associated with a
significant decrease in nGM (43.7% vs. 41.7%, p < 0.001), nWM (31.1% vs 30.2%, p <
0.05), and nWBV (74.7% vs. 71.9%, p < 0.001; see Figure 2.4A).
Figure 2.2 (next page). Cross-sectional plots of gray and white matter, normalized for
head size. (A) Cross-sectional plot of nGM across the adult life-span; each data point
represents a unique participant from a single scanning session. For participants with
follow-up data, the session with nearest-in-time clinical data is used (see Table 1). The
best-fit polynomial regression is drawn only for the nondemented individuals (blue) and
is represented by the dashed line for women (55.1 – 0.065[AGE] – 0.001[AGE2]) and
the solid line for men (54.4 – 0.076[AGE] – 0.001[AGE2]). (B) Cross-sectional plot of
nWM across the adult life-span. The dashed line represents the nondemented, female
regression (30.4 + 0.089[AGE] – 0.001[AGE2]); the solid line represents the
nondemented, male regression (30.3 + 0.100[AGE] – 0.001[AGE2]). Note the inflection
in the nWM curves (around age 42 for men and 45 for women) and the greater
separation between nondemented and DAT individuals (red versus blue) in the nGM
plot. DAT = dementia of the Alzheimer type; nGM = normalized gray matter; nWM =
normalized white matter.
27
FIGURE 2.2
A 60
55
50
nGM (%)
45
40
35
Nondemented, male DAT, male
Nondemented, female DAT, female
30
0
10 20 30 40 50 60 70 80 90 100
Age (Years)
B 40
35
nWM (%)
30
25
20
0
10 20 30 40 50 60 70 80 90 100
Age (Years)
28
TABLE 2.2. Estimated gray, white, and whole-brain volume (WBV) by age decade in
nondemented individuals
Age ± SD, Gray ± SD, White ± SD, WBV ± SD,
Age decade n yrs cm3 cm3 cm3
Female
Male
29
Longitudinal. The longitudinal dataset, obtained in older adults, is plotted in Figure 2.3B.
The whole-brain atrophy rate in nondemented older adults was -0.45% (SD = 0.53) per
year. The atrophy rate in age-matched individuals with DAT was -0.98% (SD = 1.0) per
year. A full-factorial analysis of covariance with age, gender, and dementia status at last
scan as covariates, and atrophy rate as the dependent measure, was significant (F[7,71] =
2.16, p < 0.05), with a main effect for dementia status and a significant interaction
between age and dementia status. The longitudinal, nondemented atrophy rate of -0.45%
per year showed no significant correlation with age within the older sample (r = -0.17, p
= 0.30; see Figure 2.4C) and closely matched the atrophy rate estimated from the cross-
sectional, nondemented aging curve, which varied from -0.31% to -0.46% per year over
Figure 2.3 (next page). Cross-sectional and longitudinal plots of whole-brain volume,
normalized for head size. (A) Cross-sectional plot of nWBV across the adult life-span.
The line represents the best-fit polynomial regression of all nondemented individuals
and is referred to as the cross-sectional, nondemented aging curve (85.3 + 0.013[AGE]
– 0.002[AGE2]). (B) Longitudinal plot of nWBV in older adults (note scale change);
lines connect nWBV at baseline and follow-up scans (or the best fit, for participants
with multiple follow-ups), such that the slope of each line as a proportion of baseline
nWBV represents an individual’s atrophy rate. The slope of the thick blue line
represents the estimated longitudinal rate of change for all of the nondemented
individuals and overlaps with the slope of the cross-sectional, nondemented aging curve
(shown in black). The slope of the thick red line represents the longitudinal rate of
change for all of the DAT individuals and suggests accelerated volume loss in DAT.
Lines connected by blue triangles and red squares represent individuals who converted
from a CDR of 0 to 0.5 during the inter-scan interval; they are included in the DAT
mean. CDR = clinical dementia rating; DAT = dementia of the Alzheimer type; nWBV
= normalized whole-brain volume.
30
FIGURE 2.3
A 90
85
80
nWBV (%)
75
70
65
S Nondemented
DAT
60
0
10 20 30 40 50 60 70 80 90 100
Age (Years)
B 85
80
75
nWBV (%)
70
65
S Nondemented
DAT
60
0
60 65 70 75 80 85 90 95 100
Age (Years)
31
Of the 43 nondemented (CDR 0) individuals followed longitudinally from their first scan,
six declined to a CDR of 0.5 at the time of their last scan. Figure 2.4B compares the rate
of atrophy in individuals based on their CDR scores at first and last scan. The rate of
those who started with a CDR of 0 and declined (-0.88% per year, SD = 0.60) matched
the rate of those who started with CDR of 0.5 (-0.90% per year, SD = 0.74). Post-hoc
testing revealed a trend toward a difference (t[41] = 3.03, p = 0.09) between the
nondemented group (CDR 0 → 0) and the decliner group (CDR 0 → 0.5), though the
Figure 2.4 (next page). Summary data. (A) Mean cross-sectional nWBV for individuals
65 and over separated by CDR (0, 0.5, and 1). All differences are significant. (B)
Longitudinal atrophy rates, expressed in nWBV loss per year relative to baseline, are
separated by CDR status at first and last session. Atrophy rate was significantly greater
for the group entering the experiment with very mild dementia (CDR 0.5 → 0.5/1) than
the group entering without dementia that remained stable (CDR 0 → 0) and resembles
the rate for the group that manifested the earliest signs of DAT during the experiment
(CDR 0 → 0.5), though we await confirmation in a larger sample. (C) Individual
atrophy rates are plotted versus age, with the trendline drawn through the CDR 0 → 0
group showing minimal acceleration with age. DAT = dementia of the Alzheimer type;
CDR = clinical dementia rating.
32
FIGURE 2.4
A 76
74 N=94
nWBV (%)
72
N=69
70
N=29
68
0
66
CDR 0 CDR 0.5 CDR 1
-0.2
Atrophy (%/yr)
-0.4 N=37
-0.6
-1.0
-1.2
-1
-2
60 65 70 75 80 85 90 95
Age (Years)
33
DISCUSSION
whole-brain volume was detected in early adulthood and continued into old age, with
distinct patterns for gray- and white-matter loss. The cross-sectional rate of decline
overlapped the longitudinal rate in the older, nondemented adults. For the longitudinal
subset of older adults in the earliest stages of DAT, the rate of whole-brain atrophy (-
0.98% per year) was more than twice the nondemented rate (-0.45% per year), indicating
marked acceleration. These main results are elaborated in terms of the three questions
2.3A) shows that normalized, whole-brain volume (nWBV) declined from 85% at age 20
to 74% at age 80, a lifespan atrophy rate of 0.23% per year, in general agreement with
prior studies. Table 2.3 summarizes the results from twelve cross-sectional MR reports on
healthy aging that cover the adult lifespan and report whole-brain or gray/white-matter
estimates as a percentage of head size. A number other reports are qualitatively similar,
but employ quantitatively distinct units that cannot be directly compared to the present
results (Pfefferbaum et al., 1994, Harris et al., 1994, Christiansen et al., 1994, Murphy et
al., 1996, Raz et al., 1997, Passe et al., 1997, Jernigan et al., 2001, Rovaris et al., 2003,
Sullivan et al., 2004, Raz et al., 2004). As the median of all estimates shown in Table 2.3,
nWBV declines from 89% at age 20 to 78% at age 80 (median 0.23% per year atrophy).
34
age 34 to 97, argues in favor of the generaralizablilty of this sample and these findings
(DeCarli et al., 2004). Comparable pathologic estimates fall below the range in Table 2.3;
a quadratic regression of volumetric data from one such study suggests that across the
reference age range (20-80), brain volume as a percentage of cranial cavity volume
decreased from 92% to 85% (0.14% per year atrophy; Davis and Wright 1977). This
early study employed a volumetric method involving fluid displacement that did not
account for ventricular volume and likely overestimated brain volume and
underestimated atrophy.
35
TABLE 2.3. Comparative whole brain estimates from cross-sectional, MR studies
Predicted Predicted Vol Age
Sample Mean nWBV at nWBV at decline, correlation, Best-fit
Reference size age age 20, % age 80, % %/yr r regression
Ge 02 54 47 90 78 -0.24
Mean 89 79 -0.23
Notes: nWBV = normalized whole-brain volume, employing head-size correction. Predicted nWBV at
ages 20 and 80 was interpolated from regression formulas or plots of whole-brain or gray plus white
volume relative to head size as a function of age. Rate of volume decline was estimated by dividing the
change in nWBV per year by linearly interpolated nWBV at study age.
36
In addition to quantifying the magnitude of volume decline, the present results
converge with others on a temporal sequence placing brain volume reduction at or before
the start of early adulthood (Pfefferbaum et al., 1994, Giedd et al., 1999, Courchesne et
al., 2000, Rovaris et al., 2003, Sowell et al., 2003, Salat et al., 2004). Whole-brain
volume decline was significant within the adult sample when it was restricted to age 18 to
30, although greater volume reductions were noted in the older adults as compared to the
young adults. The significant age correlation in this youngest subset argues against a
sample contaminated with preclinical AD (i.e., individuals with the pathologic substrate
age, around the inflection point of the normalized white-matter (nWM) curve at age 44
(see Figure 2.2B). Similar downward inflections (Miller et al., 1980, Harris et al., 1994)
after a period of white volume stability (Pfefferbaum et al., 1994, Blatter et al., 1995,
Guttmann et al., 1998, Good et al., 2001) or possibly growth (Courchesne et al., 2000, Ge
et al., 2002, Liu et al., 2003, Sowell et al., 2003, Jernigan and Fennema-Notestine 2004)
during the third and fourth decades have been attributed to the prolonged and
Bartzokis 2004a, Bartzokis 2004b, Sowell et al., 2004). This delayed pattern of nWM
loss (though see Van Laere and Dierckx 2001, Sullivan et al., 2004, Raz et al., 2004)
contrasts with the more linear course of normalized gray-matter (nGM) decline
37
throughout adulthood, potentially suggesting separate age-related mechanisms for each
(Raz 2004).
Gender effects were minimal in our results. For the overall cross-sectional
sample, which was not gender balanced across age, men had approximately 12% more
brain volume than women prior to head-size correction and 0.3% less after head-size
correction. The slightly more downward age-course in men than women did not reach
significance for nWBV, nGM, or nWM, but tended in the same direction as reported age-
by-gender interactions (Christiansen et al., 1994, Murphy et al., 1996, Matsumae et al.,
1996, DeCarli et al., 2004, Sullivan et al., 2004). Main gender effects from studies that
report no age-by-gender interactions can be compared with the present 0.3% normalized
volume difference: four (Blatter et al., 1995, Courchesne et al., 2000, Van Laere and
Dierckx 2001, Resnick et al., 2003) report similar gender effects (female > male), three
(Guttmann et al., 1998, Ge et al., 2002, Liu et al., 2003) report no gender effect, and three
(Raz et al., 1997, Good et al., 2001, Raz et al., 2004) report gender effects in the opposite
direction (male > female). The small magnitude of any true difference after head-size
The longitudinal rate of whole-brain atrophy averaged -0.45% per year in the
older, nondemented sample. At least seven prior studies have quantified longitudinal,
Six (Chan et al., 2001, Wang and Doddrell 2002, Liu et al., 2003, Resnick et al., 2003,
Thompson et al., 2003, Jack et al., 2004) have documented annualized rates of about -
38
0.5% (-0.37 to -0.88) , comparable to the present finding, whereas one (Tang et al., 2001)
criteria, scan resolution, and MRI maintenance may explain the divergence of the latter
study.
Returning to the present findings, the overlap between the longitudinal atrophy
longitudinal reports covering the young adult age-range (Giedd et al., 1999, Liu et al.,
2003) find slower atrophy rates than in this older, longitudinal sample, suggesting that the
trend toward accelerated atrophy with age in Figure 2.4C might reach significance with
wider longitudinal sampling or increased sample size. Together, our results indicate that
volume estimates. For instance, if developmental conditions varied among sampled age
cohorts, such that people born in more recent years tended to have increased brain
volume in proportion to head size than people born in earlier years, we would expect the
slope of the cross-sectional aging curve to exceed the longitudinal slope. A difference
might similarly result if aging mechanisms were idiosyncratic and either the longitudinal
longitudinal and cross-sectional cohorts. Instead, the observed agreement suggests that
the brain loses volume with age according to uniform and predictable, though largely
39
It is well established that individuals with DAT exhibit decreased brain volume
relative to their nondemented peers, with the underlying pathology prominent in regions
within the medial temporal lobe (Hubbard and Anderson 1981, Braak and Braak 1997,
Price et al., 2001). MRI studies have detected accelerated global and regional volume
change in DAT (Jernigan et al., 1991, Kantarci and Jack 2003). In addition, comparing
nondemented aging with DAT in Figure 2.2 tentatively suggests that gray matter is more
vulnerable than white matter to very mild to mild AD pathology (Thompson et al., 2003).
Our longitudinal data indicate a -0.98% per year whole-brain atrophy rate in the
earliest stages of DAT (CDR 0.5). This rate can be directly compared to recent estimates
for nondemented individuals who converted to DAT during follow-up (-0.8%) and those
with slow-progressing (-0.6%) and fast-progressing (-1.4%) DAT at baseline (Jack et al.,
2004). Faster whole-brain atrophy rates (-5.2%; Thompson et al., 2003) and (-2.4%;
Wang et al., 2002) have been reported in smaller cohorts with more advanced AD
(baseline MMSEs < 20). Other estimates of longitudinal whole-brain change in DAT
derive from the brain-boundary shift integral (BBSI), which models boundary changes in
serially-registered scans (Fox and Freeborough 1997). With at least one exception
(Cardenas et al., 2003), atrophy rate estimates based on the BBSI have exceeded -2% per
year (Fox and Freeborough 1997, Chan et al., 2003), for example, a -2.37% BBSI atrophy
rate in 54 DAT patients (Chan et al., 2001). Divergence in longitudinal atrophy rates may
reflect differences in atrophy measurements and DAT cohorts; the DAT sample yielding
the -2.37% estimate had a lower age (61 versus 79) and MMSE (20 versus 26) than in the
40
Providing evidence that the specific DAT sample represents an important factor,
in a sample of 5 “preclinical” familial cases followed during their conversion to DAT, the
atrophy rate was found to be -1.23% per year using the BBSI and -1.08% per year using
TIV correction, very similar to the rates reported here (Schott et al., 2003). The estimates
here and in the literature suggest that non-familial, late-onset DAT is characterized by at
least a 1% per year volume loss in its earliest clinical presentation with acceleration as
the disease progresses (Chan et al., 2003). This initial rate of brain volume loss represents
Our results tentatively suggest that accelerated loss in whole-brain volume may
begin in the preclinical phase of AD (DeKosky and Marek 2003). In particular, the small
sample of nondemented individuals who declined over the course of our observation
period showed accelerated atrophy rates similar to the individuals with very mild DAT at
automated whole-brain measures such as nWBV, combined with their potential to detect
preclinical AD, highlights the promise of global volumetric biomarkers (Jack et al.,
2004).
41
CHAPTER 3
Fischl and colleagues (2004) recently reported a model for magnetic resonance
segmentation procedure (Fischl et al., 2002) to the acquisition parameters (repetition time
[TR], echo time [TE], and flip angle) used to sequence acquisition of fast low-angle shot
sequence optimized for segmentation. The motivation for developing MEF was that it
disorders. We tested whether MEF could advance the efficiency of longitudinal studies in
follow-up period of three months represents the shortest interval reported to date relative
to comparables studies that have aimed to discriminate atrophy in AD from normal aging
were evenly divided among a nondemented (CDR 0) group and a dementia of the
Alzheimer’s type (DAT, CDR 0.5/1) group, based on their Clinical Dementia Rating
(CDR, Morris 1993), as previously described (Fotenos et al., 2005). Follow-up images
42
were acquired a mean 95 (SD = 11) days after baseline. Ten additional young adults were
scanned twice within a short interval (mean 11 days) to allow estimation of measurement
TABLE 3.1. Longitudinal sample with complete baseline and follow-up MEF images
Test-retest CDR 0 DAT (CDR 0.5) DAT (CDR 1)
Number 10 15 9 6
Age ± SD, y 27 ± 10 80 ± 10 78 ± 5 75 ± 4
(19-54) (63-95) (72-85) (70-79)
Education ± SD, y 16 ± 3 15 ± 2 15 ± 2
(12-23) (12-18) (12-16)
MMSE ± SD 29 ± 1 26 ± 3 19 ± 4
(26-30) (21-30) (15-23)
(van der Kouwe 2005). The protocol consisted of an initial fast FLASH sequence (TR =
2.4 ms, TE = 1.13 ms, resolution = 3.3 x 2.5 x 2.5 mm, time = 0:48 min) for online rigid-
body registration to a template, thus ensuring uniform head positioning during all
subsequent scans. Standard FLAIR (TR = 1000, TE = 1.13, 3.3 x 2.5 x 2.5, 3:42) and
MPRAGE (TR = 2730,TE=3.41, 1.3 x 1.0 x 1.3, 8:46) runs followed. Next came the two
main MEF sequences (TR = 20; TE = 1.8, 3.62, 5.44, 7.26, 9.08, 10.9, 12.72, 14.54, 1.3 x
1.0 x 1.3, 8:12), the first T1-weighted at a flip angle of 30 (MEF30) and the second
43
corrected MEF5 and two more fast FLASH sequences were acquired, one with the head
coil and the other with the body coil, for use in correcting B1 inhomogeneity. The multi-
gigabyte MEF k-space data was reconstructed off-line, and the resulting 16 images from
the main MEF30 and MEF5 runs, along with pre-processing output, are shown in Figure
3.1.
FIGURE 3.1
B
A
Figure 3.1. Multi-echo FLASH (MEF) imaging from one older adult participant. (A)
The eight echoes from the T1-weighted MEF30 sequence (top row) and proton-
density (PD) weighted MEF5 sequence (bottom row) show intensity decay as echo-
time increases to the right, reflecting dephasing of transverse magnetization (T2*). (B)
Weighted average of the MEF scans. (C) Synthesized T1, (D) T2*, and (E) PD maps.
(F) Standard, 8-minute structural image (MPRAGE), acquired as a control in the
imaging protocol.
44
Preprocessing of the MEF images acquired at each imaging session consisted of
four main steps: 3-D gradient unwarping; rigid registration of MEF5 to MEF30 images;
weighted averaging; and voxel-wise T1, T2*, and PD parameter estimation. Gradient
unwarping corrected for geometric distortion caused by nonlinearities in the gradient coil;
the 3-D implementation improved on the 2-D algorithm installed on the Siemens Sonata.
Head movement between acquisition of the MEF30 and MEF5 scans was corrected by 6-
paramater affine transformation (Smith et al., 2004). The transformed images were then
maximized contrast-to-noise between manually segmented gray and white voxels (Han
parameter estimates were synthesized based on the Bloch equation and changes in TE
and flip angle (α) in the MEF sequence. The Bloch equation specifies the relationship
1 − e −TR / T 1
S (m, β ) = PD sin α e −TE / T 2* , (0.1)
1 − cos α e −TR / T 1
Morphometric analysis started with the resulting MEF images (see Figure 3.1B-
E). Figure 3.2 summarizes the main analytical strategies and results. Three-month change
in CDR 0 and DAT groups was compared in terms of whole brain and regional atrophy
and relaxometry parameters. In preparation for these analyses, the three-month data was
45
registered to the baseline using a nine-parameter affine transform (translation plus
rotation plus stretch), and this transform was algebraically composed with the baseline-
to-atlas transform (12-parameter affine) so that each participant’s structural data was
corrected in atlas space for serial differences in head position and scanner drift
(Freeborough et al., 1996, Snyder 1996). The atlas template was composed of a
subsample of combined young-and-old data in the atlas space of Talairach and Tournoux
whole brain volume (nWBV) at baseline and follow-up was computed using the
between sessions at the edge of the segmented brain image was integrated for a direct
Maps of regional atrophy were derived from adding a nonlinear registration (fluid
warping) step after the rigid body registration, as previously described (Buckner et al.,
2005). Fluid warping aims to transform the follow-up image so that the difference
between follow-up and baseline is minimized (Christensen et al., 1996, Miller 2004). The
expansion, and, when divided by the intersession interval, has units of fractional loss or
gain per year. Divergence maps were compared between CDR 0 and DAT groups using
voxel-wise t-tests. The maps of relaxometry estimates, and relaxometry change maps,
were also compared using t-tests, as well as by visual inspection of individual intensity
distributions.
46
The global atrophy (Figure 3.2A, right), regional atrophy (Figure 3.2B, right), and
relaxometry analyses (Figure 3.2C) all showed no significant difference for three-month
change between CDR 0 and DAT groups. Test-retest error (Figure 3.2A, left), computed
as the mean absolute volume change (as a percentage of whole brain volume) between
scan pairs just days apart, was 0.24% for MPRAGE pairs acquired as described in
Chapter 2 (n = 23), 0.27% for MPRAGE pairs acquired as part of the present MEF
protocol, and 0.25% for the MEF-average pairs (p = 0.93). Analysis of baseline whole
brain volume (not shown) indicated that DAT was associated with a marginal decrease
(nWBV 69% vs. 67%, p = 0.06). In contrast, change estimates over the three-month
interval substantially overlapped between groups, with global atrophy rates of 1.2%/yr in
the CDR 0 group and 1.4%/yr in the DAT group (p = 0.77). Similarly, three-month
regional (voxel-wise) atrophy (see Figure 3.2B, right) did not show the pattern of parietal
and medial temporal discrimination over years-long intervals reported elsewhere for DAT
(Scahill et al., 2002, Toga and Thompson 2003). This convergent pattern is reprinted for
reference from our lab (Buckner et al., 2005) along with unpublished t-maps for standard
MPRAGE images acquired in 44 CDR 0 and 40 DAT participants over a mean two-year
interval (Figure 3.2B, left). Finally, the distribution of T1, T2*, and PD estimates in
participant’s relaxometry maps also substantially overlapped (see Figure 3.2C), and these
estimates had low reliability (for example, > 2% mean absolute percentage difference for
whole brain T1; see also DeMyer et al., 1988, Wang et al., 2004).
47
Figure 3.2 (next page). Post-processing and null results for three-month
discrimination with multi-echo FLASH (MEF). (A) Whole brain atrophy in terms of
mean absolute estimates of error from test-retest sampling (left) and annualized
change from three-month sampling (right). (B) Regional discrimination of DAT and
CDR 0 groups over two years of follow-up from Buckner and colleagues (left;
Buckner et al., 2005) with no discrimination over three months (right). (C)
Overlapping distributions of T1, T2*, and PD estimates from baseline relaxometry
maps.
48
FIGURE 3.2
A
0.4
0.0
CDR 0 CDR 0.5/1
0.3
-0.5
Error (%)
Atrophy (%/Yr)
0.2 -1.0
-1.5
0.1
-2.0
Z=38
Z=38
Z=-22
Z=-22
C Young
180 180 100 CDR 0
160 160 90
100 100
50
80 80
40
60 60
30
40 40 20
20 20 10
0 0 0
0 1000 2000 3000
0 4000 50 5000 100 0 150 3000 6000
200 9000 12000 15000 18000
49
Results from this study suggest that structural MRI based on the newly developed
MEF sequence does not lead to ready improvement in standard volumetric estimates,
such that three-month change in nondemented vs. demented samples overlapped. This
null result converges with limitations encountered in related work on the application of
the MEF sequence within the laboratory responsible for its innovation (Xiao Han,
personal communication, July 11, 2005). In contrast, a recent report based on standard
to 2, n = 38) found that interval change over 6-12 months, particularly in the volume of
the lateral ventricles, was sufficient for discrimination from nondemented aging (Schott
et al., 2005; see also, Gunter et al., 2003). This finding suggests that sampling and
improving the efficiency of structural imaging studies. We have noted the possibility, for
contributor to test-retest error, since the mean absolute percentage difference for
estimated total intracranial volume (eTIV), computed prior to segmentation, and for
normalized whole brain volume (nWBV), computed after, are both around 0.5%
(Buckner et al., 2004, Fotenos et al., 2005). Simply put, the complexity of volumetric
estimation is likely an important factor in measurement error. Based on the result with
ventricular change noted above, we suggest that a promising direction for future research
unprocessed MRIs. Such a specialized tool could take advantage of the high contrast and
50
stereotypy of ventricular CSF, and possibly also multi-spectral information, such as
51
CHAPTER 4
ABSTRACT
aging in nondemented older adults, including the role of preclinical Alzheimer’s disease
(AD). Methods: Head-size adjusted whole brain volume (aWBV) was estimated from
MRI in 362 individuals age 18 to 93. Of these, SES was assessed in a main cohort of 100
MRI) using the Hollingshead two-factor index of social position. 83 of these participants
longitudinally. To test whether preclinical AD can influence brain volume, MRI data
were analyzed from a sample of 58 CDR 0 participants (age 47 to 86) who had
aWBV was estimated to decline by 0.22%/yr between the ages of 20 and 80, with
accelerated decline in advanced aging. In older adults > 65, increasing SES was
associated with smaller aWBV (3.8% difference spanning the sample range from middle
to high privilege) and more rapid volume loss (0.39%/yr to 0.68%/yr from middle to high
52
individuals positive for PIB binding (n = 9) as compared to individuals negative for PIB
binding (n = 49). Follow-up clinical data revealed the volume reduction associated with
SES was greater in those who developed signs of very mild dementia subsequent to MRI
(stable CDR 0 group, n = 64). Conclusions: Brain volume loss is accelerated in privileged
nondemented older adults relative to less privileged peers. The capacity of more
expression, as predicted by the cognitive reserve hypothesis, may contribute to this effect.
53
INTRODUCTION
adolescence, or earlier, and continue into advanced aging (Giedd et al., 1999, Courchesne
et al., 2000, Raz et al., 2005). Relevant to Alzheimer’s disease (AD), volume loss
accelerates markedly in the earliest stages of the disease (Fox and Schott 2004, Jack et
al., 2004, Fotenos et al., 2005). These and related observations lead to the conclusion that
Hedden and Gabrieli 2005). Measurement of whole brain volume differences between
volume in a large cohort of nondemented older adults and to supplement this analysis
Compound-B (PIB) and longitudinal clinical assessment. The primary motivation is the
observation that high SES, representing both educational and occupational attainment, is
a protective factor for AD (Zhang et al., 1990, Stern et al., 1995, Bennett et al., 2003,
Amieva et al., 2005; reviewed in Scarmeas and Stern 2004, Valenzuela and Sachdev
pathology (Katzman 1993, Satz 1993), active capability to compensate for the disease
54
(Stern 2002, Stern 2006), ascertainment bias (Tuokko et al., 2003) or any combination of
these possibilities. Analysis of whole brain volume including its relation to amyloid
binding (as a proxy measure for AD pathology) and longitudinal clinical evaluation (as a
Direct precedent for this research comes from Coffey and colleagues (Coffey et
al., 1999), who observed that years of formal education may amplify volume decline in
(CSF) adjusted for age and head size. An intriguing possibility is that socioeconomically
privileged individuals are better able to respond to the initial stages of neurodegenerative
disease and their impairment does not reach a level that is clinically apparent. This notion
vivo measurement of amyloid via PIB binding reached levels suggestive of AD pathology
2005, Fagan et al., 2006, Mintun et al., 2006). Post-mortem, 34% (14/41) of participants
from our center who were nondemented at expiration nevertheless met established
histologic criteria for AD (Galvin et al., 2005). The discrepancy between post-mortem
Katzman et al., 1988, Price and Morris 1999, Esiri et al., 2001, Bennett et al., 2006, Lippa
55
and Morris 2006; reviewed in Mortimer et al., 2005), and the term “preclinical AD”
The preclinical period may relate to cognitive reserve, with longer preclinical
occupational attainment, literacy, IQ, and active lifestyle. The literature on incident
dementia offers indirect evidence for this reserve hypothesis, finding that higher reserve
variables predict less frequent disease expression (reviewed in Fratiglioni et al., 2004,
Valenzuela and Sachdev 2006). More direct evidence has come from recent studies that
and disease expression; the reserve hypothesis predicts that increasing reserve raises the
pathological threshold for impairment, and the results of these clinicopathologic studies
carefully screened for dementia, is brain volume associated with SES? We used the
education, but also weights for occupational attainment over the extended period between
schooling and retirement (Hollingshead 1957). The dependent measure was a reliable,
validated metric of whole brain volume (Buckner et al., 2004, Fotenos et al., 2005), and
the sample was screened for dementia based on the sensitive, informant-based CDR scale
(Morris 1993, Carr et al., 2000, Storandt et al., 2006). Extrapolating from the reported
result on education (Coffey et al., 1999), we hypothesized that individuals with a life
56
experience of higher SES (more combined educational and occupational attainment)
nondemented sample with follow-up MRI over an extended interval, we explored the
association between longitudinal brain aging and SES. Extending our cross-sectional
prediction, we hypothesized that brain volume loss within individuals over time would be
that they are more likely to experience atrophy associated with preclinical AD (Coffey et
al., 1999). A group with preclinical AD and other brain pathologies may be contained
within the nondemented sample; in this subgroup, atrophy is expected to advance longer
prior to disease progression in individuals with more reserve. We explored this possibility
AD pathology (PIB+ binding) were contained within our nondemented population and
further whether brain volume differs in these individuals compared to PIB- peers. Based
on the hypothesis that preclinical AD is a cause of reduced brain volume in the most
(from no dementia to very mild dementia) to explore whether the interaction of SES with
clinical conversion accounts for the brain volume reduction. Support for the reserve
57
hypothesis would come from finding that brain volume loss was accounted for by
METHODS
Participants. MRI images from 362 individuals (age 18 to 93) were obtained from
Disease Research Center (ADRC) and our ongoing studies of normal aging and
development (Berg et al., 1998, Galvin et al., 2005). More detailed attrition and selection
characteristics of this population have been described previously (Fotenos et al., 2005).
All participants were scanned with identical procedures. A subset of 100 nondemented
older adults (age 65 to 93) comprised the main cohort of clinically screened individuals
for which extensive data analysis was performed. Of these 100, 33 were followed by MRI
for an extended interval to allow for longitudinal data analysis (mean = 3.1 times over a
baseline MRI was 0. Clinicians determined the CDR, blind to the results of
participant and interview with an informant (usually a family member) who knew the
participant well and could provide information regarding decline from the participant’s
normal cognitive and functional abilities (Morris 1993). Designation of CDR 0.5 (very
58
baseline, in contrast to impaired test performance relative to group norms in mild
cognitive impairment (Morris et al., 2001, Storandt et al., 2006). The orientation of the
CDR to intraindividual change helps to avoid mistaking low baseline functioning for
dementia or, conversely, mistaking no dementia for high baseline functioning in the
sensitivity to early symptomatic AD, a recent report from our center found that over one
third (276 of 728) of a CDR 0.5 sample had neuropsychological test scores that did not
fall below the required cutoffs for MCI (pre-MCI group), despite the presence of
In the present study, the mean duration between clinical assessment and baseline
MRI was 116 days (range = 0 to 314 days). Participants were paid for their participation
and gave informed consent in accordance with guidelines of the Washington University
Human Studies Committee. Data from some of these participants have been reported in
previous studies (Salat et al., 2004, Head et al., 2005, Fotenos et al., 2005, Buckner et al.,
SES was assessed for all older adults at a participant’s initial clinical evaluation,
using the Hollingshead two-factor index of social position (Hollingshead 1957). The
occupational attainment, with occupation almost doubly weighted. The index ranges from
11 to 77 and can be grouped into five SES categories (I-V). In order to control for
59
1994; reviewed in House and Williams 2000) and because the cohort from which data
were drawn contains too few low-SES individuals to disentangle these effects, this study
focused on variation of the Hollingshead index within the range of the high-privilege,
high-middle, and middle SES groups (I-III; Fratiglioni et al., 1999). None of the health
variables presented in the table of sample characteristics (Table 4.1) differed between
these groups.
60
TABLE 4.1. MRI sample
Young Middle Aged Nondemented Old (CDR 0)
61
each of six domains assessed by the CDR. A Sum Box Score of 0.5 indicates very mild impairment in one
domain other than memory; all participants had a global CDR of 0, indicating no dementia. Mean values
are given ± the standard deviation. Values in parenthesis represent the range. MMSE = Mini-Mental State
Examination where scores range from 30 (best) to 0 (worst); BP = blood pressure; CDR = Clinical
Dementia Rating; SES = socioeconomic status.
Estimation of whole brain volume. Our method of image acquisition and brain volume
estimation has been described previously (Buckner et al., 2004, Fotenos et al., 2005).
prepared rapid gradient echo (MP-RAGE) images were acquired on a 1.5-T Vision
scanner (Siemens, Erlangen, Germany). Repetition time was 9.7 ms, echo time was 4 ms,
flip angle was 10°, inversion time was 20 ms, and resolution was 1 × 1 × 1.25.
intensity inhomogeneity (B1 bias-field), skull masking, and segmentation into gray,
white, and CSF compartments. The registration was based on computation of a 12-
paramater affine transformation aimed at minimizing variance between the first MP-
RAGE and a combined young-and-old template in the atlas space of Talairach and
Tournoux (Talairach and Tournoux 1988, Snyder 1996, Buckner et al., 2004). Estimated
total intracranial volume (eTIV) was computed based on the atlas transformation.
Specifically, the atlas scaling factor (ASF), which represents the determinant of the
volume (TIV, r = 0.93) and minimally biased by atrophy (Buckner et al., 2004). The
inverse of the ASF was used as the eTIV, as in our earlier report (Fotenos et al., 2005).
The segmentation used a validated algorithm for computing the maximum likelihood
62
estimates of a hidden Markov, random field model, constrained by both intensity and
Whole brain volume (WBV) was computed as the sum of gray and white
compartments. Head size differences were corrected using a covariance procedure (as
estimates and covariates of interest (Mathalon et al., 1993, Buckner et al., 2004). The
volumes, as distinct from proportionally normalized whole brain volume (nWBV). The
where WBV is the uncorrected (native) whole brain volume, b is the slope of the volume
regression on eTIV, eTIV is the ASF-derived head size estimate, and mean eTIV is the
sample mean. In instances where the influences of multiple variables on WBV were
being explored simultaneously, eTIV was always entered as a covariate and the
Cross-sectional analysis. To explore differences in brain volume across the full life-span,
aWBV was plotted cross-sectionally versus age for the entire sample of 362 individuals,
including the cohort of 100 clinically screened nondemented older participants (age 65 to
63
93) and the young and middle-aged volunteers from the community (age 18 to 64), who
participated in MRI under identical conditions. Statistical analysis was conducted with
both JMP and SAS software packages (SAS Institute, Cary, NC). Analysis of covariance
and hierarchical polynomial regression were used to model aWBV as a function of age
and sex.
To test for a cross-sectional relationship between SES and brain volume, analysis
was restricted to the main carefully screened older adult sample of 100, and SES was
entered as the predictor variable, with age and sex as covariates. We limited the analysis
to whole brain estimates because they are almost twice as reliable as separated gray and
white estimates and avoid potential confounds involving white-matter intensity changes
Longitudinal analysis. To test for a longitudinal relationship between SES and brain
volume, we used multilevel modeling (SAS PROC MIXED, full maximum likelihood
estimation) with aWBV as the dependent measure and the time-by-SES term as the
predictor; covariates were baseline age, time (expressed as years from baseline), SES,
uneven number and spacing more sensitively than ordinary-least-squared (OLS) slope
analysis (Singer and Willett 2003). For visualization, however, the most precise OLS
regressions of aWBV against time were plotted per individual, with individuals ranked by
64
Preclinical Alzheimer’s disease. As will be shown, SES exerts an influence on brain
volume with the most privileged individuals showing reduced brain volume (cross-
sectional data) and accelerated volume loss (longitudinal data). The reserve hypothesis to
volume with the more privileged individuals harboring preclinical AD longer or more
frequently than in the less privileged. To explore the role of preclinical AD on brain
volume and its relation to SES, two sets of additional data were analyzed. The first
analysis, based on amyloid plaque imaging, explored whether preclinical AD could exert
an influence on brain volume. The second analysis, based on follow-up clinical data,
explored whether an interaction between SES and preclinical dementia status influenced
brain volume.
Visualization of amyloid was enabled by PIB, a radiotracer with high affinity for
amyloid in Aβ plaques (Klunk et al., 2004). As part of the larger research program at
ADRC participants that partially overlapped with the main sample. Characteristics of the
PIB sample are described in Table 4.2; 28 of those with PIB imaging overlapped the main
cohort described in Table 4.1. The rest were either younger, less privileged, or missing
SES data. Those not within the main cohort nonetheless received identical MRI. The
combination of PIB-PET and structural MRI allowed us to estimate the percentage of our
nondemented sample that harbored a putative sign of AD pathology and to test whether
CDR 0 individuals with high PIB uptake (PIB+) exhibit brain volume reduction relative
65
to peers with minimal PIB uptake (PIB-). This analysis establishes whether AD in its
N (cross-sectional) 49 9
PIB-PET image acquisition and analysis are detailed elsewhere (Buckner et al.,
2005, Fagan et al., 2006, Mintun et al., 2006). Briefly, 10 mCi PIB, synthesized
according to published methods (Mathis et al., 2003), was injected into the antecubital
vein of participants resting eyes-closed in a 961 HR ECAT PET scanner (CTI, Knoxville,
TN). Images were acquired in 3-D and reconstructed into 5-min frames (septa withdrawn;
66
with scatter correction and a ramp filter; ~5.5-6 mm full width half maximum) over a 60-
min scanning interval. Frames were motion corrected and atlas registered via composition
of affine transforms of PET to MRI to atlas (Snyder 1996). PIB uptake in four brain
regions (prefrontal, lateral temporal, precuneus, and gyrus rectus) was obtained by
manual drawing of ROIs on the coregistered MRI and application to the dynamic PET
data. Binding potential (BP) was calculated using Logan graphical analysis with a
cerebellar reference ROI (Logan et al., 1996; for ROI descriptions, see Fagan et al.,
2006). A mean BP for these four regions greater than 0.2 was used to classify individuals
with higher relative cortical binding as PIB+, based on the demonstrated association
between CDR, CSF amyloid-β42, and quantitative PIB uptake (Fagan et al., 2006).
Baseline MRIs from individuals classified as PIB+ were then compared against PIB-
MRIs, in a separate analysis of the PIB sample using aWBV as the dependent measure.
For the second analysis, preclinical dementia was assessed by examining the
contrast to the limited overlapping PIB sample) allowed us to explore interactions with
SES. Specifically, 83 of the 100 participants characterized in Table 4.1 as CDR 0 around
the time of baseline MRI received at least one subsequent clinical evaluation (mean 2.9,
range 1 to 6; mean follow-up interval of 3.0 years, range 0.5 to 6.4 years). Participants
were grouped relative to their initial MRI as preclinically demented if they received a
CDR of 0.5 at any subsequent clinical examination. Group status (preclinical versus
67
stable CDR 0) was added as an additional term in the cross-sectional analysis of SES
described above.
RESULTS
nondemented individuals, age 18 to 93, are illustrated in Figure 4.1 (using covariance-
adjusted whole brain volume; aWBV). Parameter estimates for age, age2, sex, and age-
by-sex were all significant in the model (F[5,356] = 1394.14, p < 0.001, R2 = 0.95). For a
sense of effect size, aWBV can be compared at age 20 and age 80, with estimated
declines from 1199 cm3 to 1025 cm3 in men and from 1195 cm3 to 1050 cm3 in women
(decline in annualized percentage terms, 0.24%/yr and 0.20%/yr respectively). Note that
initial aWBV is almost identical between men and women, reflecting the adjustment’s
ability to accommodate head size differences (Buckner et al., 2004). The significance of
the quadratic age term reflects the acceleration of volume decline in advanced aging.
Considering the age range between 65 and 80, the estimated declines were 0.40%/yr for
68
FIGURE 4.1
1250
1200
Adjusted Whole Brain Volume (cm3)
1150
1100
1050
1000
950
900
0
10 20 30 40 50 60 70 80 90 100
Age (Years)
Figure 4.1. Cross-sectional plot of brain volume in nondemented adults over the adult
life-span. Adjusted whole brain volume (aWBV, shown adjusted for head size)
declines 13% (0.22%/year) between age 20 and age 80; deviation from a linear time-
course is mild, though significant.
Privileged older adults have reduced brain volume. Figure 4.2A focuses on the role of
SES as a potential modifier of whole brain volume among nondemented older adults (age
> 65 yr). After accounting for effects of age, sex, and age-by-sex on aWBV (model
F[5,94] = 218.74, p < 0.001, R2 = 0.92), more privileged individuals were associated with
lower volume estimates (β = 1.3 cm3 per Hollingshead unit, p < 0.01). For example,
spanning the sample range from middle privilege (Hollingshead = 43) to highest privilege
69
(Hollingshead = 11), aWBV was estimated to decrease from 1066 to 1026 cm3 (3.8%
difference).
Privileged older adults show accelerated longitudinal volume loss. To determine whether
cross-sectional differences associated with SES relate to aging, volume change was
estimated within participants using longitudinal MRI (Figure 4.2B). Consistent with the
(time-by-SES β = 0.11 cm3 per year per Hollingshead, p < 0.05), controlling for sex-by-
time and main effects of SES and time within the multilevel model (χ2 = 191.96, d.f. = 3,
p < 0.001; adding baseline age did not contribute). For example, spanning the
longitudinal sample range from middle privilege (Hollingshead = 40) to highest privilege
(Hollingshead = 11), model estimates of aWBV loss nearly doubled from 4.3 cm3/yr to
estimates for the time-by-SES interaction (β = 0.11 cm3 per year per Hollingshead unit, p
< 0.05) were obtained with a model of aWBV controlling for baseline aWBV (χ2 =
70
Figure 4.2 (next page). Cross-sectional and longitudinal plots of brain volume as a
function of socioeconomic status. (A) Cross-sectional adjusted whole brain volume
(aWBV, shown adjusted for effects of head size, age, and sex) is reduced in more
privileged individuals (1.3 cm3 per Hollingshead unit). Each data point represents a
nondemented older adult from the main sample of 100. (B) Longitudinal aWBV from
33 of the above 100 who participated in follow-up MRI; here each data point
represents an MRI, with best-fit lines connecting each participants’s data. Lines are
positioned according to participants’ Hollingshead, and time is nested with 5 years
scaled as shown (Hollingshead does not vary per individual). Baseline reduction in
aWBV with privilege is readily apparent in the longitudinal subgroup. The downward
tilting in slope with privilege (time-by-SES interaction) is more subtle, though visible,
and of primary interest. Modeling predicts an increase in volume loss from 4.3 cm3/yr
to 7.4 cm3/yr across the sample range, after accounting for effects of baseline age,
SES, and sex (aWBV is shown adjusted for head size). SES = socioeconomic status,
with privilege shown increasing from left to right, based on the Hollingshead two-
factor index of social position
71
FIGURE 4.2
A 1150
1050
1000
950
1150
B
5 yrs
1100
Adjusted Whole Brain Volume (cm3)
1050
1000
950
72
TABLE 4.3. Summary Data
Adjusted Whole Brain Volume ± SD (n), cm3 Change ± SD (n), cm3/y
SES All (100) Stable CDR 0 (64) Preclinical CDR 0 (19) Longitudinal (33)
Middle 1058 ± 59 (31) 1057 ± 54 (20) 1095 ± 20 (5) -4.8 ± 3.2 (7)
High-Middle 1038 ± 42 (40) 1041 ± 44 (26) 1022 ± 35 (8) -6.6 ± 3.3 (15)
High 1029 ± 40 (29) 1025 ± 42 (18) 1017 ± 37 (6) -6.8 ± 2.5 (11)
Notes: Mean values ± standard deviation for cross-sectional volume and longitudinal change estimates.
Adjusted whole brain volume (aWBV) is shown for the main nondemented sample of 100, as well by
group for the sub-sample with clinical follow-up. For summary, WBV was adjusted only for eTIV on the
n = 100 sample (see text for estimates after correcting for additional covariates). Summary change
estimates were based on the slopes of ordinary-least-square regressions through each participant’s sample
of aWBV measurements over time. SES = socioeconomic status.
Evidence that reserve may be an important factor in AD. Figures 4.3 and 4.4 display
results that explore aWBV in relation to amyloid imaging with PIB and follow-up clinical
assessments. The results, in composite, suggest brain volume differences linked to SES
are associated with preclinical dementia. First, 9 of 58 individuals (16%) within the
separate CDR 0 PIB sample (ages 47 to 86) summarized in Table 4.2 were positive for
PIB binding, suggesting many may harbor preclinical AD. Second, Figure 4.3 shows that
there was a main effect (p < 0.05) of positive PIB binding on brain volume: aWBV was
estimated to decline 27 cm3 (2.5%, from 1066 to 1039 cm3) in the CDR 0 PIB+ group,
after adjusting for effects of age (model F[3,54] = 151.62, p < 0.001, R2 = 0.89). This
73
Third, Figure 4.4 offers tentative support for a contribution of preclinical
dementia to the effect of SES depicted in Figure 4.2A. Participants were grouped as
preclinical if subsequent clinical evaluation using the CDR indicated the onset of very
mild dementia (CDR 0.5). Adding group status to the cross-sectional model (F[7,92] =
1.9 cm3 per Hollinshead per clinical conversion, p = 0.08; the interaction term became
significant [β = 2.4, p < 0.05] when the model was run on the full nondemented sample,
nondemented.) The magnitude of the interaction predicts that the cross-sectional decline
in aWBV with privilege (β = 1.3 cm3 less aWBV per Hollingshead unit overall) will
increase by 1.9 cm3 per Hollingshead unit in individuals with preclinical dementia.
74
FIGURE 4.3
1080
1070
Adjusted Whole Brain Volume (cm 3)
n = 49
1060
*
1050
1040
n=9
1030
10200
CDR 0 PIB- CDR 0 PIB+
Figure 4.3. Adjusted whole brain volume (aWBV, shown adjusted for effects of head
size and age) is 27 cm3 (2.5%) lower in nondemented participants with high uptake of
PIB, which binds to amyloid-β in plaques. PIB = [11C]Pittsburgh Compound-B (PIB);
CDR = Clinical Dementia Rating, with 0 indicating no dementia.
75
FIGURE 4.4
5 yrs
1150
CDR 0.5
1100
Adjusted Whole Brain Volume (cm3)
1050
1000
950
Figure 4.4. The relationship between adjusted whole brain volume (aWBV, as shown
in Figure 2A) and SES is stronger in nondemented participants who subsequently
develop dementia. Each data point represents the same nondemented older adult as
shown in Figure 2A for the 83 participants who received clinical follow-up
subsequent to MRI. Lines extending from each point represent the duration of clinical
follow-up, with 5 years nested and scaled as shown. A vertical tick marks when
certain participants received a CDR of 0.5, indicating very mild dementia. These
participants are classified as preclinically demented with respect to MRI, acquired
when all were nondemented (CDR 0). The magnitude of the decline in aWBV with
privilege is tentatively greater in the preclinical group. As shown, the best-fit
regressions decline by 1.4 cm3 per Hollingshead in the stable CDR group and 3.4 cm3
per Hollingshead in the preclinical group. CDR = Clinical Dementia Rating; SES =
socioeconomic status, with privilege shown increasing from left to right, based on the
Hollingshead two-factor index of social position.
76
DISCUSSION
Nondemented participants with high SES (the most privileged individuals) were
found to have reduced whole brain volume (cross-sectional analysis) and accelerated
volume loss (longitudinal analysis). The capacity for more privileged individuals to cope
longer with brain pathology before manifesting signs of dementia, consistent with the
SES associated with brain volume reduction in nondemented aging. The main result in
the present paper is the strong evidence that high SES is associated with lower adjusted
whole brain volume in nondemented older adults (see Figure 4.2). It is worth
head size (reviewed in Rushton and Ankney 1996, Wickett et al., 2000). This focus on
change is clear in the longitudinal result, which shows accelerated volume loss in more
privileged individuals, but even the cross-sectional analysis indirectly uses individuals as
their own control, primarily in the adjustment for head size. Thus, baseline differences in
head size across SES levels do not account for the present results. Moreover, in the
present sample, we did not find significant head size differences attributable to SES.
Our main cross-sectional finding (Figure 4.2A) replicates and strengthens the
most comparable study from Coffey and colleagues (Coffey et al., 1999). Spanning a
representative range of their sample from 8 to 17 years of education, peripheral CSF was
77
reported to increase by 15.9 cm3 (1.7% of whole brain mean; for a similar result with
analysis restricted to patients with probable AD, see Kidron et al., 1997). Peripheral CSF
was defined from traced structures as cranial minus brain minus ventricular volume, and
its increase was interpreted as indirect evidence of greater age-related brain volume
decline in the more educated. The negative finding for the direct measure of whole brain
analysis to a direct measure of whole brain volume using estimates from multiple high
The longitudinal finding illustrated in Figure 4.2B confirms the direction of the
association between volume and privilege and provides novel evidence that this
association is related to aging and present in older age. The overall rate of decline with
age (6.36 cm3/yr or 0.58%/yr) is within the range (0.37%/yr to 0.88%/yr) reported by
comparable studies with longitudinal MRI of the whole brain in nondemented older
adults (reviewed in Fotenos et al., 2005). Considering the accelerated atrophy rate
associated with SES in this study (ranging from of 0.39%/yr to 0.68%/yr between middle
and high privilege), it is possible that some of the variance between prior studies arose
The role of preclinical AD and cognitive reserve. What explains these results? Based on
similar cross-sectional findings in advanced aging (Coffey et al., 1999) and AD (Kidron
et al., 1997), others have offered theoretical accounts invoking the cognitive reserve
hypothesis (see also Kramer et al., 2004, Scarmeas and Stern 2004). In addition to clear
78
documentation of the influence of SES on brain volume, we present here three novel
observations. First, 16% of our nondemented PIB sample showed high levels of binding
preclinical AD. Second, high PIB binding was associated with reduced aWBV (Figure
4.3). Third, in the larger sample with follow-up clinical data, a trend for a group-by-
privilege interaction was observed with reduced aWBV associated with more privileged
individuals who soon showed signs of very mild dementia (Figure 4.4). This interaction
was significant when considering all nondemented individuals, including those without
follow-up clinical assessment. Together, these results suggest that AD-dependent atrophy
(Gosche et al., 2002, den Heijer et al., 2006, Jagust et al., 2006). The interaction clarifies
the association with SES and suggests that the most privileged individuals are able to
harbor neurodegenerative disease further into its course without clinical detection. While
indirect, evidence for accelerated atrophy linked to disease also suggests that preclinical
pathology may have advanced to the point of influencing cellular integrity or cell loss
(Terry et al., 1991, Price et al., 2001), and this underscores the potential of volumetric
A reserve explanation for our results is consistent with recent evidence that more
prior to AD diagnosis (Amieva et al., 2005, Scarmeas et al., 2006). Other studies have
controlled for AD pathology and shown that the same plaque burden lead to less global
79
cognitive decline in more educated groups (Bennett et al., 2003, Bennett et al., 2005).
greater reserve would be expected to have more advanced pathology in order to explain
why they show more severe structural or functional decline. In this study, assuming
pathology develops independent of reserve variables (Del Ser et al., 1999, Bennett et al.,
2003, Mortimer et al., 2005; though see Jankowsky et al., 2005, Lazarov et al., 2005),
exclusion related to SES. The present data thus are consistent with SES influencing the
ability to detect cognitive impairment in the presence of pathology and possibly cell loss.
It is unclear whether there is any modification of the underlying disease process by life
experiences associated with SES. Education and occupational attainment may protect
against AD through a “use it and hide it” mechanism in comparison to the more
Limitations and caveats. Limitations of this study highlight open questions and may help
to guide future research. The present study explored SES between the middle and high
range. Thus, our results cannot speak to how low SES affects brain aging and AD, and
future structural research in the underprivileged is needed (Del Ser et al., 1999, Mortimer
et al., 2003).
80
Not all reports exploring reserve and brain volume measures find an association in
nondemented older adults (Coffey et al., 1992, Passe et al., 1997, Raz et al., 2005). The
that the association holds for this sample. Sample and measurement differences may
account for null findings, and we are aware of no contradictory studies that suggest a
occupational attainment on brain aging (for review of modifiers, see Kramer et al., 2004,
Van Petten 2004). Replication in additional large-sample studies will be important for
A final point to raise is that, while the present results support a cognitive reserve
model, further data will be required to test the model and to explore whether it can fully
account for all of the data or whether additional factors are at work. Specifically, it
remains difficult to account fully for the magnitude of the SES-related volume difference
unless the reserve differential is longer and/or CDR 0 pathology more burdensome than
recent research suggests (Amieva et al., 2005, Bennett et al., 2005, Galvin et al., 2005).
We thus conclude that cognitive reserve likely explains some, but perhaps not all, of the
81
CHAPTER 5
GENERAL DISCUSSION
Centenarians are the most rapidly growing age group in the United States (Wan et
al., 2005). One centenarian who serves as an example of successful aging is Sister
Marcella. When Sister Marcella died, age 101, at the Counsel Hill convent of the School
Sisters of Notre Dame, she had been followed as part of the Nun Study for four years
(Snowdon 2003). Up until her death, she rated her ability to care for herself as
“excellent.” She was known for her remarkable memory and storytelling, and cognitive
testing confirmed a high and maintained level of function. At autopsy, her brain was
largely free of pathology: it weighed 1280 grams, was rated Braak stage 0 (Braak and
As Sister Marcella’s example makes clear, advanced age is not synonymous with
AD and dementia. This thesis has compared structural brain change between demented
and nondemented adults. Underlying our experimental strategy has been the hypothesis
that multiple factors may contribute independently to demented and nondemented brain
aging (Berg 1985, Morris 1999, Della-Maggiore et al., 2002, Buckner 2004, Hedden and
Gabrieli 2005). This multiple factor framework compares to a unitary framework that
places AD and dementia at the tail-end of a single aging continuum (Brayne and
Calloway 1988, Whalley 2002, Bartzokis 2004, de la Torre 2004a). Taken together, the
results of this thesis strengthen the multiple factor framework. We thus review our results
82
in terms of AD and non-AD factors that may separately contribute to age-related
Figure 5.1 (next page). Thesis results within a multiple factor framework of brain
aging. This figure summarizes the main results in the left column, with the middle and
right columns showing which parts on the left are hypothesized to reflect AD (middle
column) and non-AD (right column) factors. Possible pathophysiological processes
underlying such factors are discussed within the text. (A) From Figure 2.3; note the
possibility that that separate non-AD processes (right column) may contribute to
early-onset (black) and older-onset (blue) components of the adult-span curve; (B)
from Figure 3.2; and (C) from Figure 4.3. See individual figure legends for details.
83
FIGURE 5.1
Brain Volume
Brain Volume
Brain Volume
Age
Brain Volume
Age Age
Age
B
DAT CDR 0 DAT CDR 0 DAT CDR 0
Z=38
Z=38
Z=38
Z=-7
Z=-7
Z=-7
Z=-22
Z=-22
Z=-22
Brain Volume
Brain Volume
84
Before elaborating on this decomposition, what might AD and non-AD factors
misfolding and toxicity (Selkoe 2004, Walsh and Selkoe 2004) and sporadic small vessel
disease (SVD) as a process of microvasculature fibrosis and ischemia (Pugh and Lipsitz
2002, Ringelstein and Nabavi 2005, Farkas et al., 2006). We begin with a brief overview
of this pathophysiology. In the case of AD, alterations in four genes have been identified
that cause early-onset or accelerated late-onset familial disease; strikingly, all have been
oligomers (Dodart et al., 2002) and diffuse and fibrillar plaques (Urbanc et al., 2002)
have been found to interfere with synaptic function and associate with the activation of
microglia and astrocytes, though gaps remain in the mechanism linking Aβ to tauopathy.
In DAT, loss of synapses strongly correlates with cognitive decline (Terry et al., 1991,
(Spaan et al., 2003, Galvin et al., 2005). Tauopathy and atrophy progress sequentially
(Braak et al., 1999, Delacourte et al., 1999), with early involvement of medial temporal
regions and associated neocortex (see Figure 3.2B; also Buckner et al., 2005); Aβ
85
Ringelstein and Nabavi 2005). The implicated mutation weakens the contact between
vascular smooth muscle cells (Shawber and Kitajewski 2004), a possible model for how
hyperlipidemia (Longstreth et al., 1996, Laloux et al., 2004, Ringelstein and Nabavi
2005), may function in sporadic (wild-type) SVD. MRI findings in SVD include lacunar
atrophy, most prominently in frontal white matter (Weis et al., 1991, Double et al., 1996,
Head et al., 2004). Though sporadic SVD may rarely progress to frank vascular dementia
declines on measures of executive function, cognitive speed, affect, gait, and bladder
control (Sakakibara et al., 1999, de Groot et al., 2000, Schmidtke and Hull 2002, Wolfson
et al., 2005, Charlton et al., 2006). In summary, sporadic AD and SVD are both widely
prevalent, adverse, age-related processes, but SVD has a distinct pathological signature,
SVD represents a plausible non-AD factor in the cause of common and consequential
age-related brain change, providing context for the following decomposition of these
steady volume decline even in the youngest adults, with atrophy rate more than doubling
in the earliest stages of DAT. By itself, the acceleration of structural loss in DAT does
inspection raises at least three problems for the unitary account. First, as Figure 2.3A
86
makes clear, whole brain volume in the oldest old nondemented individuals falls below
the range for the younger old with dementia. This deviation from a directly proportional
relationship between volume decline and DAT suggests that certain factors that do not
for age-related volume decline in young adults (<30) in terms of known pathological
trajectory may start in adolescence (Buckner et al., 2005, Courchesne et al., 2000, Liu et
al., 2003). Third, the decomposition of whole brain volume into gray and white
compartments in Figure 2.2 shows a mostly linear course for gray decline and nonlinear
course for white matter, again consistent with potentially independent factors.
an anatomical dissociation. Although the statistical maps in Figure 3.2B showed minimal
difference between DAT and CDR 0 groups for three-month change, there were
significant differences in the reference study with longer (mean two-year) follow-up
(from Buckner et al., 2005). Atrophy in DAT was most prominently accelerated in medial
temporal regions and a distributed network of parietal cortex, including the precuneus,
posterior cingulate, retrosplenium, and lateral posterior parietal regions. The basis for a
relationship between medial temporal atrophy and parietal atrophy in the natural history
the anatomical dissociation of AD and non-AD factors, prefrontal atrophy was prominent
in the nondemented sample, but there was no acceleration in these prefrontal regions in
87
related prefrontal atrophy may be independent of AD (Hubbard and Anderson 1981,
key unresolved question is how non-AD factors contribute to age-related change in white
matter versus gray matter (Raz 2004). Neuroimaging methods for measuring white matter
aging focus on change in relaxometry (white matter hyperintensities and infarcts), water
diffusion along and dependent on the integrity of fiber tracts (diffusion tensor
anisotropy), and structure (white matter volume loss). It remains unclear whether
vascular disease linked to these white matter changes, another pathological process, or a
loss. Modifier studies will be key to resolving questions of cause and effect in brain aging
and motivated our interest in a candidate modifier, socioeconomic status (SES), in our
final study.
Our SES results draw attention to uncertainties and interactions within the
multiple factor framework. We found a positive association between SES and age-related
volume loss in nondemented older adults. Yet we also found evidence that preclinical AD
may account for this association. Preclinical AD represents a source of uncertainty in the
imaging (see Figure 4.3) suggest that atrophy may accelerate in association with high
plaque binding prior to the onset of dementia (see also Kaye et al., 1997, Fox et al., 1999,
Gosche et al., 2002, Marquis et al., 2002, Archer et al., 2006, den Heijer et al., 2006,
88
Jagust et al., 2006). A methodological implication is that observational studies may be
aging. For example, to determine whether SES associates with accelerated brain aging,
not just in the absence of dementia, but in the absence of potential pathological factors,
interventional designs would offer the best control. Neuroimaging studies along these
lines might assign participants to high- and low-intensity education courses, or (a quasi
intervention) track students during the school-year versus summer months (see also
Lastly, we have argued that the reserve hypothesis may explain why SES relates
most strongly to brain volume in nondemented participants on the cusp of dementia (see
Figure 4.4). Reserve represents the accumulated capacity to buffer and compensate for
pathology; as a reserve variable, SES is a putative proxy for this lifetime process of
accumulation (Stern 2006). The simplifying assumption has generally been that
accumulation of reserve has no effect on AD or brain aging. However, our results leave
pathology (Jankowsky et al., 2003, Kamenetz et al., 2003, Cirrito et al., 2005, Lazarov et
al., 2005; reviewed in Selkoe 2006). As more preclinical candidates are identified with
PIB, it will be interesting to test whether amyloid pathology, and not just dementia risk,
interaction (Snowdon et al., 1996, Snowdon et al., 2000). For in the final analysis, the
decomposition of aging into multiple factors as discussed above is just a first step toward
89
understanding how AD, vascular disease, reserve, and other physiological and
90
REFERENCES
of Alzheimer's 1907 paper, "Uber eine eigenartige Erkankung der Hirnrinde". Clin
Anat 8:429-31.
Archer HA, Edison P, Brooks DJ, Barnes J, Frost C, Yeatman T, Fox NC, Rossor MN
11:805-821.
Neuroimage 14:1238-1243.
91
Bartzokis G (2004b) Quadratic trajectories of brain myelin content: unifying construct for
Bennett DA, Schneider JA, Wilson RS, Bienias JL, Arnold SE (2005) Education modifies
the association of amyloid but not tangles with cognitive function. Neurology
65:953-955.
Bennett DA, Wilson RS, Schneider JA, Evans DA, de Leon C, Arnold SE, Barnes LL,
Bennett DA, Schneider JA, Arvanitakis Z, Kelly JF, Aggarwal NT, Shah RC, Wilson
Berg L, McKeel DW, Miller JP, Storandt M, Rubin EH, Morris JC, Baty J, Coats M,
Norton J, Goate AM, Price JL, Gearing M, Mirra SS, Saunders AM (1998)
Blatter DD, Bigler ED, Gale SD, Johnson SC, Anderson CV, Burnett BM, Parker N,
92
Bookstein FL (2001) "Voxel-based morphometry" should not be used with imperfectly
Borenstein AR, Copenhaver CI, Mortimer JA (2006) Early-life risk factors for Alzheimer
Boxer AL, Rankin KP, Miller BL, Schuff N, Weiner M, Gorno-Tempini ML, Rosen HJ
Alzheimer's disease: what is new since A. Alzheimer? Eur Arch Psych Clin
Neurosci 249:14-22.
Neuropathol 82:239-259.
Bradley KM, Bydder GM, Budge MM, Hajnal JV, White SJ, Ripley BD, Smith AD
(2002) Serial brain MRI at 3-6 month intervals as a surrogate marker for
Brayne C, Calloway P (1988) Normal ageing, impaired cognitive function, and senile
Broca P (1861) Sur le volume et la forme du cerveau suivant les individus et suivant les
93
Brun A, Gustafson L (1976) Distribution of cerebral degeneration in Alzheimer's disease.
Buckner RL, Head D, Parker J, Fotenos AF, Marcus D, Morris JC, Snyder AZ (2004) A
unified approach for morphometric and functional data analysis in young, old, and
Neuroimage 23:724-738.
Buckner RL, Snyder AZ, Shannon BJ, LaRossa G, Sachs R, Fotenos AF, Sheline YI,
Klunk WE, Mathis CA, Morris JC, Mintun MA (2005) Molecular, structural, and
Buckner RL (2004) Memory and executive function in aging and AD: multiple factors
that cause decline and reserve factors that compensate. Neuron 44:195-208.
Burns JM, Church JA, Johnson DK, Xiong CJ, Marcus D, Fotenos AF, Snyder AZ,
Morris JC, Buckner RL (2005) White matter lesions are prevalent but differentially
related with cognition in aging and early Alzheimer disease. Arch Neurol 62:1870-
1876.
Callen D, Black SE, Gao F, Caldwell CB, Szalai JP (2001) Beyond the hippocampus -
1674.
94
Cardenas VA, Du AT, Hardin D, Ezekiel F, Weber P, Jagust WJ, Chui HC, Schuff N,
Carr DB, Gray S, Baty J, Morris JC (2000) The value of informant versus individual's
Chan D, Fox NC, Jenkins R, Scahill RI, Crum WR, Rossor MN (2001) Rates of global
57:1756-1763.
Chan D, Janssen JC, Whitwell JL, Watt HC, Jenkins R, Frost C, Rossor MN, Fox NC
Charlton RA, Morris RG, Nitkunan A, Markus HS (2006) The cognitive profiles of
27:934-946.
Christensen GE, Rabbitt RD, Miller MI (1996) Deformable templates using large
dependent white matter lesions and brain volume changes in healthy volunteers.
95
Cirrito JR, Yamada KA, Finn MB, Sloviter RS, Bales KR, May PC, Schoepp DD, Paul
Coffey CE, Saxton JA, Ratcliff G, Bryan RN, Lucke JF (1999) Relation of education to
brain size in normal aging - implications for the reserve hypothesis. Neurology
53:189-196.
Coffey CE, Wilkinson WE, Parashos IA, Soady SAR, Sullivan RJ, Patterson LJ, Figiel
GS, Webb MC, Spritzer CE, Djang WT (1992) Quantitative cerebral anatomy of the
Neurology 42:527-536.
Coggan JS, Grutzendler J, Bishop DL, Cook MR, Gan WB, Heym J, Lichtman JW
Neurobiol 60:214-226.
Colcombe SJ, Erickson KI, Raz N, Webb AG, Cohen NJ, McAuley E, Kramer AF (2003)
Aerobic fitness reduces brain tissue loss in aging humans. J Gerontol Ser A-Biol Sci
Coleman PD, Yao PJ (2003) Synaptic slaughter in Alzheimer's disease. Neurobiol Aging
24:1023-1027.
96
Csernansky JG, Hamstra J, Wang L, McKeel D, Price JL, Gado M, Morris JC (2004)
1153.
Davatzikos C (2004) Why voxel-based morphometric analysis should be used with great
Davis P, Wright EA (1977) A new method for measuring cranial cavity volume and it
Neurobiol 3:341-358.
de Groot JC, de Leeuw FE, Oudkerk M, Hofman A, Jolles J, Breteler M (2000) Cerebral
white matter lesions and depressive symptoms in elderly adults. Arch Gen
Psychiatry 57:1071-1076.
Dekaban AS (1978) Changes in brain weights during the span of human life: relation of
brain weights to body heights and body weights. Ann Neurol 4:345-56..
DeKosky ST, Marek K (2003) Looking backward to move forward: early detection of
97
Del Ser T, Hachinski V, Merskey H, Munoz DG (1999) An autopsy-verified study of the
Neurology 52:1158-1165.
Della-Maggiore V, Grady CL, McIntosh AR (2002) Dissecting the effect of aging on the
DeMyer MK, Gilmor RL, Hendrie HC, DeMyer WE, Augustyn GT, Jackson RK (1988)
den Heijer T, Geerlings MI, Hoebeek FE, Hofman A, Koudstaal PJ, Breteler M (2006)
predict dementia in cognitively intact elderly people. Arch Gen Psychiatry 63:57-
62.
Dodart JC, Bales KR, Gannon KS, Greene SJ, DeMattos RB, Mathis C, DeLong CA, Wu
98
without reducing brain A beta burden in Alzheimer's disease model. Nat Neurosci
5:452-457.
Double KL, Halliday GM, Kril JJ, Harasty JA, Cullen K, Brooks WS, Creasey H, Broe
427:311-312.
Duan HL, Wearne SL, Rocher AB, Macedo A, Morrison JH, Hof PR (2003) Age-related
Esiri MM, Matthews F, Brayne C, Ince PG, Matthews FE, Xuereb JH, Broome JC,
175.
Fagan AM, Mintun MA, Mach RH, Lee SY, Dence CS, Shah AR, LaRossa GN, Spinner
ML, Klunk WE, Mathis CA, DeKosky ST, Morris JC, Holtzman DM (2006)
Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid a
99
Farkas E, de Vos R, Donka G, Steur E, Mihaly A, Luiten P (2006) Age-related
Feinberg I, Thode HC Jr, Chugani HT, March JD (1990) Gamma distribution model
describes maturational curves for delta wave amplitude, cortical metabolic rate and
Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, van der Kouwe A,
Fischl B, Salat DH, van der Kouwe A, Makris N, Segonne F, Quinn B, Dale AM (2004)
23:S69-S84.
Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method
for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-
198.
Fotenos AF, Snyder AZ, Girton LE, Morris JC, Buckner RL (2005) Normative estimates
Neurology 64:1032-1039.
Fox NC, Freeborough PA (1997) Brain atrophy progression measured from registered
Imaging 7:1069-1075.
100
Fox NC, Schott JM (2004) Imaging cerebral atrophy: Normal ageing to Alzheimer's
Fox NC, Warrington EK, Rossor MN (1999) Serial magnetic resonance imaging of
lifestyle in late life might protect against dementia. Lancet Neurol. 3:343-353.
Freeborough PA, Woods RP, Fox NC (1996) Accurate registration of serial 3D MR brain
Galton F (1888) Head growth in students at the University of Cambridge. Nature 38:14-
15.
Galvin JE, Powlishta KK, Wilkins K, McKeel DW Jr, Xiong C, Grant E, Storandt M,
Ge YL, Grossman RI, Babb JS, Rabin ML, Mannon LJ, Kolson DL (2002) Age-related
total gray matter and white matter changes in normal adult brain. Part I: Volumetric
Giedd JN, Blumenthal J, Jeffries NO, Castellanos FX, Liu H, Zijdenbos A, Paus T, Evans
101
Giedd JN (2004) Structural magnetic resonance imaging of the adolescent brain. Ann NY
Glenner GG, Wong CW (1984) Alzheimer's disease: initial report of the purification and
Commun 120:885-890.
Brys M, de Leon MJ (2005) The role of quantitative structural imaging in the early
Good CD, Johnsrude IS, Ashburner J, Henson R, Friston KJ, Frackowiak R (2001) A
Neuroimage 14:21-36.
Gosche KM, Mortimer JA, Smith CD, Markesbery WR, Snowdon DA (2002)
Goulding MR, Rogers ME, Smith SM (2003) Public health and aging: Trends in aging -
Gunter JL, Shiung MM, Manduca A, Jack CR (2003) Methodological considerations for
Gur RC, Mozley PD, Resnick SM, Gottlieb GL, Kohn M, Zimmerman R, Herman G,
brain atrophy measured by magnetic resonance imaging. Proc Natl Acad Sci USA
88:2845-2849.
102
Gurland B (1981) The borderlands of dementia: the influence of sociocultural
Alzheimer's disease and senile dementia (Miller N, Cohene G, eds), Vol 15. pp 61-
Gusnard DA, Raichle ME (2001) Searching for a baseline: Functional imaging and the
Guttmann C, Jolesz FA, Kikinis R, Killiany RJ, Moss MB, Sandor T, Albert MS (1998)
Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: Progress and
Harris GJ, Schlaepfer TE, Peng LW, Lee S, Federman EB, Pearlson GD (1994) Magnetic
Haug H, Kuhl S, Mecke E, Sass NL, Wasner K (1984) The significance of morphometric
Head D, Buckner RL, Shimony JS, Williams LE, Akbudak E, Conturo TE, McAvoy M,
103
Head D, Snyder AZ, Girton LE, Morris JC, Buckner RL (2005) Frontal-hippocampal
double dissociation between normal aging and Alzheimer's disease. Cereb Cortex
15:732-739.
new evidence from neuroimaging of the aging brain. Curr Opin Neurol 18:740-747.
Hollingshead AB (1957) Two factor index of social position. Technical report 1-11.
House JS, Lepkowski JM, Kinney AM, Mero RP, Kessler RC, Herzog AR (1994) The
disparities in health. In: Promoting health: intervention strategies from social and
Hubbard BM, Anderson JM (1981) A quantitative study of cerebral atrophy in old age
Jack CR, Dickson DW, Parisi JE, Xu YC, Cha RH, O'Brien PC, Edland SD, Smith GE,
Neurology 58:750-757.
104
Jack CR, Shiung MM, Gunter JL, O'Brien PC, Weigand SD, Knopman DS, Boeve BF,
Ivnik RJ, Smith GE, Cha RH, Tangalos EG, Petersen RC (2004) Comparison of
different MRI brain atrophy rate measures with clinical disease progression in AD.
Neurology 62:591-600.
681.
Jankowsky JL, Melnikova T, Fadale DJ, Xu GM, Slunt HH, Gonzales V, Younkin LH,
25:5217-5224.
Jernigan TL, Archibald SL, Fennema-Notestine C, Gamst AC, Stout JC, Bonner J,
Hesselink JR (2001) Effects of age on tissues and regions of the cerebrum and
Aging 25:37-39.
Jernigan TL, Press GA, Hesselink JR (1990) Methods for measuring brain morphologic
features on magnetic resonance images. Validation and normal aging. Arch Neurol
47:27-32.
105
Jernigan TL, Salmon DP, Butters N, Hesselink JR (1991) Cerebral structure on MRI, Part
29:68-81.
hereditary arteriopathy causing brain infarcts and dementia. Brain Pathol. 12:371-
384.
Karas GB, Scheltens P, Rombouts S, Visser PJ, van Schijndel RA, Fox NC, Barkhof F
(2004) Global and local gray matter loss in mild cognitive impairment and
preserved mental status and numerous neocortical plaques. Ann Neurol 23:138-144.
Katzman R (1993) Education and the prevalence of dementia and Alzheimer's disease.
Neurology 43:13-20.
Kaye JA, Swihart T, Howieson D, Dame A, Moore MM, Karnos T, Camicioli R, Ball M,
Oken B, Sexton G (1997) Volume loss of the hippocampus and temporal lobe in
106
Kidron D, Black SE, Stanchev P, Buck B, Szalai JP, Parker J, Szekely C, Bronskill MJ
Klunk WE, Engler H, Nordberg A, Wang YM, Blomqvist G, Holt DP, Bergstrom M,
Savitcheva I, Huang GF, Estrada S, Ausen B, Debnath ML, Barletta J, Price JC,
influences on cognitive and brain plasticity during aging. J Gerontol Ser A-Biol Sci
Laloux P, Galanti L, Jamart J (2004) Lipids in ischemic stroke subtypes. Acta Neurol.
Belg 104:13-19.
Launer LJ, Andersen K, Dewey ME, Letenneur L, Ott A, Amaducci LA, Brayne C,
T, Hofman A, CA EURODEM Incidence Res Grp Work Grp (1999) Rates and risk
factors for dementia and Alzheimer's disease - Results from EURODEM pooled
107
Lazarov O, Robinson J, Tang YP, Hairston IS, Korade-Mirnics Z, Lee V, Hersh LB,
Lee HG, Casadesus G, Zhu XW, Takeda A, Perry G, Smith MA (2004) Challenging the
Liu R, Lemieux L, Bell GS, Sisodiya SM, Shorvon SD, Sander J, Duncan JS (2003) A
Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL (1996) Distribution
volume ratios without blood sampling from graphical analysis of PET data. J.
Longstreth WT, Manolio TA, Arnold A, Burke GL, Bryan N, Jungreis CA, Enright PL,
Maguire EA, Gadian DG, Johnsrude IS, Good CD, Ashburner J, Frackowiak R, Frith CD
108
Manly JJ, Schupf N, Tang MX, Stern Y (2005) Cognitive decline and literacy among
Marner L, Nyengaard JR, Tang Y, Pakkenberg B (2003) Marked loss of myelinated nerve
Marquis S, Moore MM, Howieson DB, Sexton G, Payami H, Kaye JA, Camicioli R
Neurol 59:601-606.
Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K (1985)
Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl
Mathalon DH, Sullivan EV, Rawles JM, Pfefferbaum A (1993) Correction for head size
Mathis CA, Wang YM, Holt DP, Huang GF, Debnath ML, Klunk WE (2003) Synthesis
Matsumae M, Kikinis R, Morocz IA, Lorenzo AV, Sandor T, Albert MS, Black PL,
109
McKeel DW, Price JL, Miller JP, Grant EA, Xiong CJ, Berg L, Morris JC (2004)
Miller AK, Alston RL, Corsellis JA (1980) Variation with age in the volumes of grey and
Miller MI, Hosakere M, Barker AR, Priebe CE, Lee N, Ratnanather JT, Wang L, Gado
M, Morris JC, Csernansky JG (2003) Labeled cortical mantle distance maps of the
cingulate quantify differences between dementia of the Alzheimer type and healthy
Miller MI (2004) Computational anatomy: shape, growth, and atrophy comparison via
110
Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH, Berg L (2001) Mild
58:397-405.
Morris JC (1993) The Clinical Dementia Rating (CDR): current version and scoring
clinicopathologic studies of healthy aging and very mild Alzheimer's disease. J Clin
Invest 104:1171-1173.
Morrison JH, Hof PR (1997) Life and death of neurons in the aging brain. Science
278:412-419.
Mortimer JA, Borenstein AR, Gosche KM, Snowdon DA (2005) Very early detection of
Alzheimer neuropathology and the role of brain reserve in modifying its clinical
Mortimer JA, Snowdon DA, Markesbery WR (2003) Head circumference, education and
risk of dementia: findings from the Nun study. J Clin Exp Neuropsychol 25:671-
679.
Morton S (1849) Observations on the size of the brain in various races and families of
Murphy DG, DeCarli C, McIntosh AR, Daly E, Mentis MJ, Pietrini P, Szczepanik J,
Schapiro MB, Grady CL, Horwitz B, Rapoport SI (1996) Sex differences in human
111
imaging and positron emission tomography study on the effect of aging. Arch Gen
Psychiatry 53:585-594.
Nolan KA, Lino MM, Seligmann AW, Blass JP (1998) Absence of vascular dementia in
Regeur L (2003) Aging and the human neocortex. Exp Gerontol 38:95-99.
Pakkenberg H, Voigt J (1964) Brain weight of the Danes. Acta Anatomica 56:297-307.
Passe TJ, Rajagopalan P, Tupler LA, Byrum CE, MacFall JR, Krishnan K (1997) Age
21:1231-1237.
112
Pfefferbaum A, Mathalon DH, Sullivan EV, Rawles JM, Zipursky RB, Lim KO (1994) A
Price JL, Ko AI, Wade MJ, Tsou SK, McKeel DW, Morris JC (2001) Neuron number in
the entorhinal cortex and CA1 in preclinical Alzheimer disease. Arch Neurol
58:1395-1402.
Price JL, Morris JC (1999) Tangles and plaques in nondemented aging and "preclinical"
Raz N, Gunning FM, Head D, Dupuis JH, McQuain J, Briggs SD, Loken WJ, Thornton
AE, Acker JD (1997) Selective aging of the human cerebral cortex observed in
vivo: Differential vulnerability of the prefrontal gray matter. Cereb Cortex 7:268-
282.
113
Raz N (2004) The aging brain observed in vivo: differential changes and their modifiers.
In: Cognitive neuroscience of aging: linking cognitive and cerebral aging (Cabeza
Raz N (2000) Aging of the brain and its impact on cognitive performance: integration of
structural and functional findings. In: Handbook of Aging and Cognition (Craick F,
Resnick SM, Pham DL, Kraut MA, Zonderman AB, Davatzikos C (2003) Longitudinal
23:3295-3301.
Roe CM, Xiong C, Miller JP, Morris JC (2006) Education and Alzheimer’s disease
Rushton JP, Ankney CD (1996) Brain size and cognitive ability: correlations with age,
114
Rusinek H, Endo Y, De Santi S, Frid D, Tsui WH, Segal S, Convit A, de Leon MJ (2004)
Neurology 63:2354-2359.
people with and without leukoaraiosis: relation to cognitive and gait function. J
Salat DH, Buckner RL, Snyder AZ, Greve DN, Desikan R, Busa E, Morris JC, Dale AM,
Fischl B (2004) Thinning of the cerebral cortex in aging. Cereb Cortex 14:721-730.
volume in analysis of whole brain atrophy in multipls Sclerosis: the proportion vs.
Satz P (1993) Brain reserve capacity on symptom onset after brain injury: a formulation
Scahill RI, Schott JM, Stevens JM, Rossor MN, Fox NC (2002) Mapping the evolution of
Scarmeas N, Albert SM, Manly JJ, Stern Y (2006) Education and rates of cognitive
Scarmeas N, Stern Y (2004) Cognitive reserve: implications for diagnosis and prevention
115
Schmidtke K, Hull M (2002) Neuropsychological differentiation of small vessel disease,
Schott JM, Fox NC, Frost C, Scahill RI, Janssen JC, Chan D, Jenkins R, Rossor MN
(2003) Assessing the onset of structural change in familial Alzheimer's disease. Ann
Neurol 53:181-188.
Schott JM, Price SL, Frost C, Whitwell JL, Rossor MN, Fox NC (2005) Measuring
Neurology 65:119-124.
Selkoe DJ (2004) Cell biology of protein misfolding: The examples of Alzheimer's and
Selkoe DJ (2006) The ups and downs of A beta. Nat Med 12:758-759.
Shawber CJ, Kitajewski J (2004) Notch function in the vasculature: insights from
Silbert LC, Quinn JF, Moore MM, Corbridge E, Ball MJ, Murdoch G, Sexton G, Kaye
Singer JD, Willett JB (2003) Applied longitudinal data analysis: modeling change and
116
Sluming V, Barrick T, Howard M, Cezayirli E, Mayes A, Roberts N (2002) Voxel-based
Bannister PR, De Luca M, Drobnjak I, Flitney DE, Niazy RK, Saunders J, Vickers
Suppl 1:S208-S219.
Smith SM, Zhang YY, Jenkinson M, Chen J, Matthews PM, Federico A, De Stefano N
Smith SM (2002) Fast robust automated brain extraction. Hum Brain Mapp 17:143-155.
Snowdon DA, Greiner LH, Markesbery WR (2000) Linguistic ability in early life and the
Snowdon DA, Kemper SJ, Mortimer JA, Greiner LH, Wekstein DR, Markesbery WR
(1996) Linguistic ability in early life and cognitive function and Alzheimer's
disease in late life - Findings from the Nun Study. JAMA 275:528-532.
Snowdon DA (2003) Healthy aging and dementia - Findings from the nun study. Ann
117
Snyder AZ (1996) Difference image vs ratio image error function forms in PET-PET
Sowell ER, Peterson BS, Thompson PM, Welcome SE, Henkenius AL, Toga AW (2003)
Mapping cortical change across the human life span. Nat Neurosci 6:309-315.
Sowell ER, Thompson PM, Leonard CM, Welcome SE, Kan E, Toga AW (2004)
Neurosci 24:8223-8231.
Sowell ER, Thompson PM, Toga AW (2004) Mapping changes in the human cortex
review of the efficiency of clinical and experimental memory measures. J Clin Exp
Neuropsychol 25:216-233.
32:371-375.
Stern Y, Alexander GE, Prohovnik I, Stricks L, Link B, Lennon MC, Mayeux R (1995)
Stern Y (2002) What is cognitive reserve? Theory and research application of the reserve
118
Stern Y (2006) Cognitive reserve and Alzheimer disease. Alzheimer Dis Assoc Dis
20:112-117.
Sullivan EV, Rosenbloom M, Serventi KL, Pfefferbaum A (2004) Effects of age and sex
major membrane components of human brain during the span of adult human life of
Swaab DF, Dubelaar E, Hofman MA, Scherder E, van Someren E, Verwer R (2002)
Brain aging and Alzheimer's disease; use it or lose it. Prog Brain Res 138:343-373.
Tang Y, Whitman GT, Lopez I, Baloh RW (2001) Brain volume changes on longitudinal
Tanzi RE, Bertram L (2005) Twenty years of the Alzheimer's disease amyloid
Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman
119
Thompson PM, Hayashi KM, de Zubicaray G, Janke AL, Rose SE, Semple J, Herman D,
Hong MS, Dittmer SS, Doddrell DM, Toga AW (2003) Dynamics of gray matter
Tisserand DJ, Pruessner JC, Arigita E, van Boxtel M, Evans AC, Jolles J, Uylings H
Neuroimage 17:657-669.
Toga AW, Thompson PM (2003) Temporal dynamics of brain anatomy. Annu Rev
Health 7:259-270.
neurogenesis, neuronal death and neuron quantification in adult CNS. Prog Brain
Res 136:39-65.
Urbanc B, Cruz L, Le R, Sanders J, Ashe KH, Duff K, Stanley HE, Irizarry MC, Hyman
transgenic mice and Alzheimer's disease. Proc Natl Acad Sci USA. 99:13990-
13995.
120
Valenzuela MJ, Sachdev P (2006) Brain reserve and dementia: a systematic review.
Van der Kouwe A (2005) MGH neuroanatomical imaging package. Technical report.
Van Laere KJ, Dierckx RA (2001) Brain perfusion SPECT: Age-and sex-related effects
221:810-817.
Van Petten C (2004) Relationship between hippocampal volume and memory ability in
Neuropsychologia 42:1394-1413.
Villareal DT, Grant E, Miller JP, Storandt M, McKeel DW, Morris JC (2003) Clinical
Vincent JL, Snyder AZ, Fox MD, Shannon BJ, Andrews JR, Raichle ME, Buckner RL
Wagner AD, Shannon BJ, Kahn I, Buckner RL (2005) Parietal lobe contributions to
Walhovd KB, Fjell AM, Reinvang I, Lundervold A, Fischl B, Salat D, Quinn BT, Makris
Walsh DM, Selkoe DJ (2004) Deciphering the molecular basis of memory failure in
121
Wan H, Sengupta M, Velkofff VA, DeBarros AK (2005) 65+ in the United States: 2005.
Wang DM, Chalk JB, Rose SE, de Zubicaray G, Cowin G, Galloway GJ, Barnes D,
volumes of brain structures. Part 1: method and validation. Magn Reson Imaging
20:27-40.
Wang HL, Yuan HS, Shu L, Xie JX, Zhang D (2004) Prolongation of T-2 relaxation
153.
Whalley LJ, Starr JM, Athawes R, Hunter D, Pattie A, Deary IJ (2000) Childhood mental
Whalley LJ (2002) Brain ageing and dementia: what makes the difference? Br J
Psychiatry 181:369-371.
Wickett JC, Vernon PA, Lee DH (2000) Relationships between factors of intelligence
122
Wolfson L, Wei XC, Hall CB, Panzer V, Wakefield D, Benson RR, Schmidt JA,
Woods RP, Cherry SR, Mazziotta JC (1992) Rapid automated algorithm for aligning and
Zhang MY, Katzman R, Salmon D, Jin H, Cai GJ, Wang ZY, Qu GY, Grant I, Yu E,
Shanghai, China: impact of age, gender, and education. Ann Neurol 27:428-437.
Zhang YY, Brady M, Smith S (2001) Segmentation of brain MR images through a hidden
123